<SEC-DOCUMENT>0000784199-16-000235.txt : 20160309
<SEC-HEADER>0000784199-16-000235.hdr.sgml : 20160309
<ACCEPTANCE-DATETIME>20160309164045
ACCESSION NUMBER:		0000784199-16-000235
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20160309
DATE AS OF CHANGE:		20160309

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYOLIFE INC
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-210046
		FILM NUMBER:		161495027

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>c199-20160309xs3.htm
<DESCRIPTION>S-3
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 5.17.1.24-->
<!--Created on: 3/9/2016 4:38:05 PM-->
<html>
	<head>
		<title>
			S-3 Registration Statement  3-7-16
		</title>
	</head>
	<body><div style="margin-left:36pt;margin-right:36pt;">
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width:541.05pt;margin-left:0pt;">
			<tr>
				<td colspan="3" valign="bottom" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<a name="_GoBack"></a><font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:95.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;border-bottom:2pt double #000000 ;padding:0pt 5.2pt;">
					<p style="margin:0pt 3.6pt 2.5pt 0pt;text-align:right;line-height:95.83%;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;">As filed with the Securities and Exchange Commission on </font><font style="display: inline;font-weight:bold;">March 9</font><font style="display: inline;font-weight:bold;">, 2016</font></p>
					<p style="margin:0pt 3.6pt 2.5pt 0pt;text-indent:36pt;text-align:right;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;">Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;border-top:2pt double #000000 ;padding:0pt 5.2pt;">
					<p style="margin:2.5pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 17pt">
						<font style="display: inline;">SECURITIES AND EXCHANGE COMMISSION</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Washington, D.C. 20549</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;height:10.00pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:left;line-height:95.83%;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 17pt">
						<font style="display: inline;">FORM S</font><font style="display: inline;">&#8209;3</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 15pt">
						<font style="display: inline;">REGISTRATION STATEMENT</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt 0.25pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Under</font></p>
					<p style="margin:12pt 0pt 0pt 0.25pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">The Securities Act of 1933</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;height:10.00pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:left;line-height:95.83%;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 17pt">
						<font style="display: inline;">CRYOLIFE</font><font style="display: inline;">, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:0.25pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">(Exact name of Registrant as specified in its charter)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;height:10.00pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:left;line-height:95.83%;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:180.40pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Florida</font></p>
				</td>
				<td colspan="4" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">59-2417093</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:180.40pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:0.25pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">(State or other jurisdiction of</font><br /><font style="display: inline;">incorporation or organization)</font></p>
				</td>
				<td colspan="4" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:0.25pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 8pt">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:0.25pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">(I.R.S. Employer</font><br /><font style="display: inline;">Identification Number)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:180.40pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="4" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">1655 Roberts Boulevard, NW Kennesaw, Georgia 30144</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">(770) 419-3355</font></p>
				</td>
				<td colspan="3" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:0.25pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">(Address, including zip </font><font style="display: inline;">code, and telephone number, including</font><font style="display: inline;"> area code, of Registrant's principal executive offices)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;height:10.00pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:left;line-height:95.83%;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:180.40pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="4" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">J. Patrick Mackin, </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Chairman, President and </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Chief Executive Officer </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">CryoLife, Inc. </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">1655 Roberts Boulevard, NW </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Kennesaw, Georgia 30144 </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">(770) 419-3355</font></p>
				</td>
				<td colspan="3" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:0.25pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:180.40pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						&nbsp;</p>
				</td>
				<td colspan="4" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:6pt 0pt 0pt;line-height:95.83%;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-style:italic;font-size:11pt;">Copies to:</font></p>
				</td>
				<td colspan="3" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:180.40pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Jean F. Holloway</font><font style="display: inline;">, Esq.,</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">General Counsel</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">CryoLife, Inc.</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">1655 Roberts Boulevard, NW</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Kennesaw, Georgia 30144</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">(770) 419-3355</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="4" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Paul R. Tobias </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Wilson Sonsini Goodrich&nbsp;&amp; Rosati </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Professional Corporation </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">900 S. Capital of Texas Highway </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Las Cimas IV, Fifth Floor </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Austin, Texas 78746-5546 </font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">(512) 338-5400</font></p>
				</td>
				<td colspan="3" valign="top" style="width:179.90pt;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Robert C. Brighton, Jr.</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Shutts &amp; Bowen LLP</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">200 East Broward Boulevard</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Suite 2100</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Fort Lauderdale, Florida 33301</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">(</font><font style="display: inline;">954</font><font style="display: inline;">) &nbsp;</font><font style="display: inline;">524-5505</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:6pt 0pt 0pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;">Approximate date of commencement of proposed sale to the public:</font><font style="display: inline;"> From time to time after the effective date of this Registration Statement.</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.&nbsp; </font><font style="display: inline;">&nbsp;</font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.&nbsp; </font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp; </font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective statement for the same offering.&nbsp; </font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.&nbsp; </font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule&nbsp;413(b) under the Securities Act, check the following box.&nbsp; </font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;height:21.15pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;"> See the definitions of &#x201C;large accelerated filer,&#x201D; &#x201C;accelerated filer&#x201D; and &#x201C;smaller reporting company&#x201D; in Rule&nbsp;12b-2 of the Exchange Act. (Check one):</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="4" valign="top" style="width:270.10pt;padding:0pt 5.2pt;">
					<p style="margin:1pt 0pt 0pt;text-indent:0pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">Large accelerated filer&nbsp; </font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></p>
				</td>
				<td colspan="5" valign="top" style="width:270.10pt;padding:0pt 5.2pt;">
					<p style="margin:1pt 0pt 0pt;text-indent:0pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:0pt; padding-right:85.6pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:66pt;text-align:left"><font style="display: inline;">Accelerated filer&nbsp; </font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:right"><font style="display: inline;"></font><font style="display: inline;"></font><a name="Check1"></a><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></font></p>
				</td>
			</tr>
			<tr>
				<td colspan="4" valign="top" style="width:270.10pt;padding:0pt 5.2pt;">
					<p style="margin:1pt 0pt 0pt;text-indent:0pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">Non-accelerated filer&nbsp; </font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></p>
				</td>
				<td colspan="5" valign="top" style="width:270.10pt;padding:0pt 5.2pt;">
					<p style="margin:1pt 0pt 0pt;text-indent:0pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:0pt; padding-right:54.6pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:35pt;text-align:left"><font style="display: inline;">Smaller reporting company&nbsp; </font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:right"><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font><font style="display: inline;"></font></font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">(Do not check if a smaller reporting company) </font></p>
				</td>
			</tr>
			<tr>
				<td colspan="9" valign="top" style="width:540.20pt;padding:0pt 5.2pt;">
					<p style="margin:6pt 0pt 0pt;text-indent:0.25pt;line-height:95.83%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10.5pt;">CALCULATION OF REGISTRATION FEE</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="bottom" style="width:159.60pt;border-top:2pt double #000000 ;padding:0pt 5.2pt;">
					<p style="margin:0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Title of Each Class of </font><br /><font style="display: inline;font-size:8pt;">Securities to</font><font style="display: inline;font-size:8pt;">&nbsp;</font><font style="display: inline;font-size:8pt;">be Registered</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:2pt double #000000 ;border-left:1pt solid #000000 ;padding:0pt 5.2pt;">
					<p style="margin:0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Amount</font><br /><font style="display: inline;font-size:8pt;">to be</font><br /><font style="display: inline;font-size:8pt;">Registered</font><font style="display: inline;font-size:8pt;"> (1)</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:2pt double #000000 ;border-left:1pt solid #000000 ;padding:0pt 5.2pt;">
					<p style="margin:0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Proposed</font><br /><font style="display: inline;font-size:8pt;">Maximum</font><br /><font style="display: inline;font-size:8pt;">Offering Price</font><br /><font style="display: inline;font-size:8pt;">Per Share (</font><font style="display: inline;font-size:8pt;">2</font><font style="display: inline;font-size:8pt;">)</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:2pt double #000000 ;border-left:1pt solid #000000 ;padding:0pt 5.2pt;">
					<p style="margin:0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Proposed</font><br /><font style="display: inline;font-size:8pt;">Maximum</font><br /><font style="display: inline;font-size:8pt;">Aggregate</font><br /><font style="display: inline;font-size:8pt;">Offering Price</font><font style="display: inline;font-size:8pt;"> (2</font><font style="display: inline;font-size:8pt;">)</font></p>
				</td>
				<td valign="bottom" style="width:95.10pt;border-top:2pt double #000000 ;border-left:1pt solid #000000 ;padding:0pt 5.2pt;">
					<p style="margin:0pt;line-height:95.83%;text-align:center;font-weight:bold;text-indent:36pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Amount of</font><br /><font style="display: inline;font-size:8pt;">Registration Fee</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="top" style="width:159.60pt;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;padding:0pt 5.2pt;">
					<p style="margin:0pt 5.75pt;text-indent: -5.75pt;line-height:95.83%;font-family:Times New Roman;font-size: 8pt">
						<font style="text-indent:0pt;margin-left:-5.75pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:8pt;">Common Stock</font>.................................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:left"><font style="display: inline;font-size:8pt;"></font></font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:2pt double #000000 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,703,699&nbsp;
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:2pt double #000000 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">$11.14&nbsp;
				</td>
				<td colspan="2" valign="bottom" style="width:95.10pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:2pt double #000000 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">$41,259,206.86&nbsp;
				</td>
				<td valign="bottom" style="width:95.10pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:2pt double #000000 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">$4,154.81&nbsp;
				</td>
			</tr></table>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width:541.05pt;margin-left:0pt;">
			<tr>
				<td colspan="10" valign="top" style="width:540.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt;">
					<p style="margin:12pt 0pt 0pt 18pt;line-height:95.83%;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">(1)</font><font style="display: inline;;font-size: 9pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;">Pursuant to Rule 416 under the Securities Act of 1933</font><font style="display: inline;">, as amended (the &#x201C;Securities Act&#x201D;</font><font style="display: inline;">), the shares of common stock registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions</font><font style="display: inline;">.</font></p>
					<p style="margin:12pt 0pt 0pt 18pt;line-height:95.83%;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
						&nbsp;</p>
					<p style="margin:12pt 0pt 0pt 17.7pt;line-height:95.83%;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">(2</font><font style="display: inline;">)&nbsp;&nbsp; </font><font style="display: inline;">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low sales prices of the registrant&#x2019;s common stock on </font><font style="display: inline;">March 7</font><font style="display: inline;">,</font><font style="display: inline;"> 2016, as reported on the New York Stock Exchange</font><font style="display: inline;">.</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="10" valign="top" style="width:540.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt;">
					<p style="margin:0pt 0pt 6pt;text-indent:18pt;text-align:left;line-height:95.83%;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:95.83%;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:54pt;">
		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;">The information in this prospectus is not complete and may be changed. </font><font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;">We</font><font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;"> may not </font><font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;">sell these securities</font><font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;"> until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;">Subject </font><font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;">to Completion, Dated March 9</font><font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;">,</font><font style="display: inline;font-weight:bold;color:#C00000;font-size:10pt;"> 2016</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:14pt;">PROSPECTUS</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-size:14pt;">CryoLife, Inc.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-size:14pt;">3,703,</font><font style="display: inline;font-size:14pt;">699</font><font style="display: inline;font-size:14pt;"> Shares </font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-size:14pt;">Common Stock</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">This prospectus relates to the resale of up to </font><font style="display: inline;color:#000000;font-size:10pt;">3,703,</font><font style="display: inline;color:#000000;font-size:10pt;">699</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;">shares of common stock of </font><font style="display: inline;color:#000000;font-size:10pt;">CryoLife</font><font style="display: inline;color:#000000;font-size:10pt;">, Inc. (&#x201C;</font><font style="display: inline;color:#000000;font-size:10pt;">CryoLife</font><font style="display: inline;color:#000000;font-size:10pt;">,&#x201D; &#x201C;we,&#x201D; &#x201C;us&#x201D; or the &#x201C;Company&#x201D;) by the selling s</font><font style="display: inline;color:#000000;font-size:10pt;">hareholder</font><font style="display: inline;color:#000000;font-size:10pt;">s identified in this prospectus.</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;"> The selling s</font><font style="display: inline;color:#000000;font-size:10pt;">hareholder</font><font style="display: inline;color:#000000;font-size:10pt;">s acquired these shares from us </font><font style="display: inline;color:#000000;font-size:10pt;">pursuant to </font><font style="display: inline;color:#000000;font-size:10pt;">an Agreement and Plan of Merger </font><font style="display: inline;color:#000000;font-size:10pt;">dated December&nbsp;2</font><font style="display: inline;color:#000000;font-size:10pt;">2</font><font style="display: inline;color:#000000;font-size:10pt;">, 201</font><font style="display: inline;color:#000000;font-size:10pt;">5</font><font style="display: inline;color:#000000;font-size:10pt;">.</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;"> The selling s</font><font style="display: inline;color:#000000;font-size:10pt;">hareholder</font><font style="display: inline;color:#000000;font-size:10pt;">s may sell these shares through public or private transactions at market prices prevailing at the time of sale or at negotiated prices.</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;"> The selling s</font><font style="display: inline;color:#000000;font-size:10pt;">hareholder</font><font style="display: inline;color:#000000;font-size:10pt;">s will receive all net proceeds from the sale of shares of our common stock in this offering.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">We may also authorize one or </font><font style="display: inline;color:#000000;font-size:10pt;">more free writing prospectuses or prospectus supplements to be provided to you in connection with these offerings.</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;"> Any related free writing prospectus or prospectus supplement may also add, update or change information contained in this prospectus.</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;"> We urge you to carefully</font><font style="display: inline;color:#000000;font-size:10pt;"> read this prospectus, any accompanying prospectus supplement, any related free writing prospectus and any documents we incorporate by reference before you make your investment decision.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">Our common stock is listed on </font><font style="display: inline;color:#000000;font-size:10pt;">the New York Stock Exchange </font><font style="display: inline;color:#000000;font-size:10pt;">under the symbol &#x201C;</font><font style="display: inline;color:#000000;font-size:10pt;">CRY</font><font style="display: inline;color:#000000;font-size:10pt;">.&#x201D;</font><font style="display: inline;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:10pt;"> On </font><font style="display: inline;color:#000000;font-size:10pt;">March 4</font><font style="display: inline;color:#000000;font-size:10pt;">, 2016</font><font style="display: inline;color:#000000;font-size:10pt;">, the last reported sale price for our common stock on </font><font style="display: inline;color:#000000;font-size:10pt;">the New York Stock Exchange </font><font style="display: inline;color:#000000;font-size:10pt;">was $</font><font style="display: inline;color:#000000;font-size:10pt;">10.83</font><font style="display: inline;color:#000000;font-size:10pt;"> per share.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">Investing in our common stock involves risks</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">.</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;"> See &#x201C;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;text-decoration:underline;">Risk Factors</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">&#x201D; beginning on page </font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">5</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;"> of this prospectus.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus.</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;">&nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:10pt;"> Any representation to the contrary is a criminal offense.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">The date of this prospectus is </font><font style="display: inline;font-size:10pt;">__________</font><font style="display: inline;font-size:10pt;">, 2016</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:54pt;">
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;">TABLE OF CONTENTS</font>
		</p>
		<p style="margin:0pt;text-align:right;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:477.75pt;margin-left:4.65pt;">
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;text-align:right;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;color:#000000;text-decoration:underline;">Page</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">ABOUT THIS PROSPECTUS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">1&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">FORWARD-LOOKING STATEMENTS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">2&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">PROSPECTUS SUMMARY</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">3&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">RISK FACTORS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">5&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">USE OF PROCEEDS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">5&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">SELLING SHAREHOLDERS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">7&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">PLAN OF DISTRIBUTION</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">8&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">LEGAL MATTERS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">13&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">EXPERTS</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">13&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">INFORMATION INCORPORATED BY REFERENCE</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">13&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:441.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;">WHERE YOU CAN FIND MORE INFORMATION</font></p>
				</td>
				<td valign="middle" style="width:36.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:11pt;text-align:right;" nowrap="nowrap">14&nbsp;
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;">No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus.</font><font style="display: inline;font-weight:bold;color:#000000;">&nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;"> You must not rely on any unauthorized information or representations.</font><font style="display: inline;font-weight:bold;color:#000000;">&nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;"> This prospectus and any accompanying supplement to this prospectus do not constitute an offer to sell, or a solicitation of an offer to purchase, any securities other than the registered securities to which they relate, nor do prospectus and any accompanying supplement to this prospectus constitute an offer to sell, or a solicitation of an offer to purchase, the securities offered by this prospectus in any jurisdiction to or from any person whom or from whom it is unlawful to make such offer or solicitation of an offer in such jurisdiction.</font><font style="display: inline;font-weight:bold;color:#000000;">&nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;"> The information contained in this prospectus is current only as of its date.</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:54pt;">
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="font-size: 11pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;"></font><font style="display: inline;color:#FFFFFF;font-size:11pt;">- &nbsp;</font><font style="display: inline;color:#FFFFFF;font-size:11pt;">1</font><font style="display: inline;color:#FFFFFF;font-size:11pt;"> &nbsp;-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;">ABOUT THIS PROSPECTUS</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620910"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a &#x201C;shelf&#x201D; registration process.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Under this shelf process, the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s identified in this prospectus may offer or sell shares of our common stock, as described in this prospectus, in one or more offerings from time to time.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">We may also authorize one or </font><font style="display: inline;color:#000000;">more free writing prospectuses</font><font style="display: inline;color:#000000;"> or prospectus supplements to be provided to you in connection with these offerings.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Any related </font><font style="display: inline;color:#000000;">free writing prospectus or prospectus supplement may also add, update or change information contained in this prospectus or in any documents that we have incorporated by reference into this prospectus and, accordingly, to the extent inconsistent, information in this prospectus is superseded by the information in any accompanying prospectus supplement or any related free writing prospectus and any documents.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">You should only rely on the information contained or incorporated by reference in this prospectus and any applicable prospectus supplement or any related free writing prospectus that we may authorize to be provided to you.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> We have not authorized any other person to provide you with different information.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> If anyone provides you with different or inconsistent information, you should not rely on it.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> You should not assume that the information in this prospectus or any applicable prospectus supplement or any related free writing prospectus is accurate as of any date other than the date on the cover of the applicable document.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Our business, financial condition, results of operations and prospects may have changed since that date.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">We urge you to read carefully this prospectus (as supplemented and amended) before deciding whether to purchase any of the shares of our common stock being offered.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-size:11pt;">-1-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;color:#000000;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">FORWARD-LOOKING STATEMENTS</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620911"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">This prospectus, any prospect</font><font style="display: inline;color:#000000;">us supplement and the information </font><font style="display: inline;color:#000000;">incorporated by reference, including the sections entitled &#x201C;Prospectus Summa</font><font style="display: inline;color:#000000;">ry&#x201D; and &#x201C;Risk Factors,&#x201D; contain</font><font style="display: inline;color:#000000;"> &#x201C;forward-looking statements&#x201D; within the </font><font style="display: inline;color:#000000;">meaning of </font><font style="display: inline;color:#000000;">Section 27A </font><font style="display: inline;color:#000000;">of the Securities Act of 1933</font><font style="display: inline;color:#000000;">, as amended (the &#x201C;Securities Act&#x201D;),</font><font style="display: inline;color:#000000;"> and Section 21E of the Securities Exchange Act of 1934, as amended</font><font style="display: inline;color:#000000;"> (the &#x201C;Exchange Act&#x201D;)</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">These forward-looking statements reflect the views of our management regarding current expectations and projections about future events and are based on currently available information.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Actual results could differ materially from those contained in these forward-looking statements for a variety of reasons, including, but not limited to, those discussed in our Annual Report on Form 10-K for the year ended </font><font style="display: inline;color:#000000;">December&nbsp;31, </font><font style="display: inline;color:#000000;">201</font><font style="display: inline;color:#000000;">5</font><font style="display: inline;color:#000000;">, Part&nbsp;I, Item 1A, &#x201C;Risk Factors,&#x201D; as well as those discussed elsewhere in this prospectus.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Other unknown or unpredictable factors also could have</font><font style="display: inline;color:#000000;"> a material adverse effect on our business, financial condition and results of operations.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Accordingly, readers should not place undue reliance on these forward-looking statements.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> The use of words such as &#x201C;anticipates,&#x201D; &#x201C;estimates,&#x201D; &#x201C;expects,&#x201D; &#x201C;intends,&#x201D; &#x201C;plans&#x201D; and &#x201C;believes,&#x201D; among others, generally identify forward-looking statements; however, these words are not the exclusive means of identifying such statements.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> We are not under any obligation and do not intend to publicly update or review any of these forward-looking statements, whether as a result of new information, future events or otherwise, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Please </font><font style="display: inline;color:#000000;">carefully review and consider the various disclosures made in this report and in our other reports filed with the </font><font style="display: inline;color:#000000;">SEC</font><font style="display: inline;color:#000000;"> that attempt</font><font style="display: inline;color:#000000;"> to advise interested parties of the risks and factors that may affect our business, prospects and results of operations.</font>
		</p>
		<p style="margin:12pt -0.1pt 0pt 0.1pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:54pt;">
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">2</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;">PROSPECTUS SUMMARY</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620912"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12pt -0.05pt 0pt 0.05pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-style:italic;color:#000000;">This summary highlights selected information contained elsewhere in this prospectus.</font><font style="display: inline;font-style:italic;color:#000000;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;"> This summary does not contain all the information that you should consider before investing in our common stock.</font><font style="display: inline;font-style:italic;color:#000000;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;"> You should read the following summary together with the more detailed information regarding our company, the common stock being registered hereby, and our financial statements and notes thereto incorporated by reference in this prospectus.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:center;font-weight:bold;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Our Company</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;">Overview</font>
		</p>
		<p style="margin:12pt -0.2pt 0pt 0.2pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">CryoLife, Inc. </font><font style="display: inline;color:#000000;">is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable human tissue for use in cardiac and vascular surgeries</font><font style="display: inline;color:#000000;">. The Company operates throughout the United States and internationally. CryoLife&#x2019;s surgical sealants and hemostats include BioGlue&#xAE; Surgical Adhesive </font><font style="display: inline;color:#000000;">(&#x201C;</font><font style="display: inline;color:#000000;">BioGlue</font><font style="display: inline;color:#000000;">&#x201D;)</font><font style="display: inline;color:#000000;">, BioFoam&#xAE; Surgical Matrix </font><font style="display: inline;color:#000000;">(&#x201C;</font><font style="display: inline;color:#000000;">BioFoam</font><font style="display: inline;color:#000000;">&#x201D;)</font><font style="display: inline;color:#000000;">, and PerClot&#xAE;, a</font><font style="display: inline;color:#000000;">n absorbable</font><font style="display: inline;color:#000000;"> powdered hemostat, which the Company distributes internationally BioGlue is FDA-approved </font><font style="display: inline;color:#000000;">as an </font><font style="display: inline;color:#000000;">adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals</font><font style="display: inline;color:#000000;"> for specified applications</font><font style="display: inline;color:#000000;"> in several other countries throughout the world. BioFoam is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery when </font><font style="display: inline;color:#000000;">cessation</font><font style="display: inline;color:#000000;"> of bleeding by ligature or conventional methods</font><font style="display: inline;color:#000000;"> is ineffective or impractical.</font>
		</p>
		<p style="margin:12pt -0.2pt 0pt 0.2pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">CryoLife also specializes in the treatment of </font><font style="display: inline;color:#000000;">severe angina</font><font style="display: inline;color:#000000;"> that is not responsive to conventional therapy </font><font style="display: inline;color:#000000;">with its </font><font style="display: inline;color:#000000;">laser console system and single-use, fiber-optic handpieces</font><font style="display: inline;color:#000000;">, used</font><font style="display: inline;color:#000000;"> to perform a surgical procedure known as Transmyocardial Revascularization. </font><font style="display: inline;color:#000000;">CryoLife </font><font style="display: inline;color:#000000;">exclusively </font><font style="display: inline;color:#000000;">distributes ProCol&#xAE;</font><font style="display: inline;color:#000000;"> Vascular Bioprosthesis for Hancock Jaffe Laboratories, Inc. and PhotoFix </font><font style="display: inline;color:#000000;font-size:6pt;top:-4pt;position:relative;line-height:100%">TM</font><font style="display: inline;color:#000000;"> for Genesee biomedical, Inc. ProCol is </font><font style="display: inline;color:#000000;">a natural biological graft derived from a bovine mesenteric vein that provides</font><font style="display: inline;color:#000000;"> vascular access for end-stage renal disease hemodialysis patients, which is </font><font style="display: inline;color:#000000;">FDA </font><font style="display: inline;color:#000000;">approve</font><font style="display: inline;color:#000000;">d for sale in the U.S.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">PhotoFix is a bovine pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde .&nbsp;&nbsp;PhotoFix has received 510(K) clearance and is indicated for use in intracardiac repair, including ventricular repair and atrial repair, great vessel repair and suture line buttressing, and pericardial closure.</font>
		</p>
		<p style="margin:12pt -0.2pt 0pt 0.2pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">T</font><font style="display: inline;color:#000000;">he cardiac</font><font style="display: inline;color:#000000;"> human tissues distributed by CryoLife include the CryoValve&#xAE; SG pulmonary heart valve or CryoValve SGPV, and the CryoPatch&#xAE; SG pulmonary cardiac patch tissue, or CryoPatch SG, both of which are processed using CryoLife&#x2019;s proprietary SynerGraft&#xAE; technology. CryoValve SGPV has FDA 510(k) clearance for the replacement of diseased, damaged, malformed, or malfunctioning native or prosthetic pulmonary valves. CryoLife&#x2019;s CryoPatch has FDA 510(k) clearance for the repair or reconstruction of the right ventricular outflow tract, which is a surgery commonly performed in children with congenital heart defects.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">CryoLife&#x2019;s vascular human tissues include its CryoVein&#xAE; and CryoArtery&#xAE; tissues, which are used in vascular reconstruction surgeries.</font>
		</p>
		<p style="margin:12pt -0.2pt 0pt 0.2pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">On February 3, </font><font style="display: inline;color:#000000;">2016, CryoLife sold its the Hemodialysis Reliable Outflow Graft (HeRO Graft) product line, which is a solution for end-stage renal disease in certain hemodialysis patients, to Merit Medical Systems, Inc. (&#x201C;Merit&#x201D;) for $18.5 million in cash. Under the terms of the agreement, Merit acquired the HeRO Graft product line, including worldwide marketing rights, customer relationships, intellectual property, inventory and certain property and equipment. </font><font style="display: inline;color:#000000;">CryoLife will continue to manufacture the HeRO Graft product </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">3</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt -0.2pt 0pt 0.2pt;font-family:Times New Roman;font-size: 11pt"><font style="display: inline;color:#000000;">line for up to six months under a transition supply agreement, after which Merit will be responsible for manufacturing. The disposal of HeRO Graft is part of a strategic shift of the Company to focus on cardiac surgery products, including the On-X heart valve.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-weight:bold;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Acquisition of </font><font style="display: inline;">On-X </font><font style="display: inline;">Life Technologies</font>
		</p>
		<p style="margin:12pt -0.05pt 0pt 0.05pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">On December&nbsp;22, 2015, CryoLife entered into an Agreement and Plan of Merger (the &#x201C;Merger Agreement&#x201D;) to acquire On-X</font><font style="display: inline;color:#000000;"> Life Technologies Holdings, Inc.</font><font style="display: inline;color:#000000;"> (&#x201C;</font><font style="display: inline;color:#000000;">On-X</font><font style="display: inline;color:#000000;">&#x201D;)</font><font style="display: inline;color:#000000;">, a Delaware corporation</font><font style="display: inline;color:#000000;"> for approximately $130.0 million, subject to certain adjustments for On-X&#x2019;s cash on hand, net working capital, and unpaid transaction expenses, consisting of approximately $91.0 million in cash and $39.0 million, or&nbsp;&nbsp;3,703,699 shares, of CryoLife&#x2019;s common stock (the &#x201C;Acquisition Shares&#x201D;)</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Pursuant to the Merger Agreement</font><font style="display: inline;color:#000000;"> and following the closing of the merger which occurred on January 20, 2016</font><font style="display: inline;color:#000000;">, On-X </font><font style="display: inline;color:#000000;">has become the</font><font style="display: inline;color:#000000;"> wholly-owned subsidiary of CryoLife. </font>
		</p>
		<p style="margin:12pt -0.05pt 0pt 0.05pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Per the Company&#x2019;s preliminary analysis, the purchase price of the transaction totaled approximately $128.1 million, consisting of cash of $93.5 million and </font><font style="display: inline;color:#000000;">3,703,</font><font style="display: inline;color:#000000;">699</font><font style="display: inline;color:#000000;"> shares of CryoLife&#x2019;s common stock</font><font style="display: inline;color:#000000;">, with a value of $34.6 million as determined on the date of closing.&nbsp;&nbsp;This purchase price is subject to several potential adjustments, including a working capital adjustment, which has not </font><font style="display: inline;color:#000000;">yet </font><font style="display: inline;color:#000000;">been finalized</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">U</font><font style="display: inline;color:#000000;">pon the closing of the merger</font><font style="display: inline;color:#000000;">, CryoLife</font><font style="display: inline;color:#000000;"> enter</font><font style="display: inline;color:#000000;">ed</font><font style="display: inline;color:#000000;"> into a Registration Rights Agreement with the </font><font style="display: inline;color:#000000;">selling shareholders on January 20, 2016 (the &#x201C;Registration Rights Agreement&#x201D;)</font><font style="display: inline;color:#000000;">, pursuant to which CryoLife </font><font style="display: inline;color:#000000;">is </font><font style="display: inline;color:#000000;">required to file</font><font style="display: inline;color:#000000;"> a Registration Statement on Form S-3 </font><font style="display: inline;color:#000000;">to </font><font style="display: inline;color:#000000;">register</font><font style="display: inline;color:#000000;"> all of</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">the Acquisition Shares for resale. </font><font style="display: inline;color:#000000;">This prospectus is part of such a registration statement file</font><font style="display: inline;color:#000000;">d on Form S-3</font><font style="display: inline;color:#000000;"> pursuant to the Registration Rights Agreement.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The On-X catalogue of products includes the On-X prosthetic aortic and mitral heart valve and the On-X asc</font><font style="display: inline;color:#000000;">ending aortic prosthesis</font><font style="display: inline;color:#000000;">.&nbsp; </font><font style="display: inline;color:#000000;">On-X also distributes CarbonAid CO</font><sub style="display: inline;color:#000000;">2</sub><font style="display: inline;color:#000000;"> diffusion catheters, manufactures Chord-X ePTFE sutures for mitral chordal replacement, and offers pyrolytic carbon coating services to other medical device manufacturers.&nbsp; </font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The On-X heart valve is a bileaflet mechanical valve composed of a graphite substrate coated with On-X&#x2019;s </font><font style="display: inline;color:#000000;">pyrolytic carbon coating.&nbsp;&nbsp;The On-X heart valve is </font><font style="display: inline;color:#000000;">available for both aortic and mitral indications and with a variety of sewing ring options to suit physician&#x2019;s preferences.&nbsp;&nbsp;The On-X AAP is an On-X aortic valve combined with a Vascutek Gelweave Valsava</font><font style="display: inline;color:#000000;font-size:6pt;top:-4pt;position:relative;line-height:100%">TM</font><font style="display: inline;color:#000000;"> Graft to allow physicians to more conveniently treat patients requiring both an aortic valve replacement and an aortic graft.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">The On-X heart valve is FDA approved for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in the </font><font style="display: inline;color:#000000;">aortic and mitral positions, and is classified as a Class III medical device.&nbsp; </font><font style="display: inline;color:#000000;">On-X distributes the On-X heart valve under Conformit&#xE9; Europ&#xE9;ene Mark product certification (&#x201C;CE Mark&#x201D;) in the EEA</font><font style="display: inline;color:#000000;">.&nbsp; </font><font style="display: inline;color:#000000;">Additional marketing approvals have been granted in several other countries throughout the world.&nbsp; </font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">CryoLife, Inc. was incorporated January&nbsp;19, 1984 in Florida. All references to &#x201C;CryoLife,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;us&#x201D; or &#x201C;our&#x201D; in this prospectus mean CryoLife, Inc., a Florida corporation, and all entities owned or controlled by CryoLife, Inc., except where it is made clear that the term means only the parent company.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Our principal executive offices are located at 1655 Roberts Boulevard, NW, Kennesaw, Georgia 30144. Our telephone number is (770)&nbsp;419-3355 and our website is located at www.cryolife.com. Information contained on our website is not part of this prospectus. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:54pt;">
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">4</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;">RISK FACTORS</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620913"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Investing in our </font><font style="display: inline;color:#000000;">common stock</font><font style="display: inline;color:#000000;"> involves risks.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> You should carefully consider the risks described under &#x201C;Risk Factors&#x201D; beginning on page </font><font style="display: inline;color:#000000;">20</font><font style="display: inline;color:#000000;"> of our </font><font style="display: inline;color:#000000;">annual report</font><font style="display: inline;color:#000000;"> on Form 10-K for the period ended </font><font style="display: inline;color:#000000;">December&nbsp;</font><font style="display: inline;color:#000000;">31, 201</font><font style="display: inline;color:#000000;">5</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">which </font><font style="display: inline;color:#000000;">are</font><font style="display: inline;color:#000000;"> incorporated by reference herein</font><font style="display: inline;">&nbsp;</font><font style="display: inline;color:#000000;">and which may be updated, supplemented or superseded by the risks and uncertainties described in the reports we subsequently file with the SEC</font><font style="display: inline;color:#000000;">, as well as the other information contained or incorporated by reference in this prospectus or any prospectus supplement hereto before making a decision to invest in our securities.</font>
		</p>
		<p style="margin:24pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">USE OF PROCEEDS</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620914"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The proceeds from the sale of the common stock offered pursuant to this prospectus are solely for the account of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Accordingly, we will not receive any proceeds from the sale of the common stock offered hereby.</font><a name="toc63139_10"></a>
		</p>
		<p style="margin:24pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">DESCRIPTION</font><font style="display: inline;font-weight:bold;font-size:11pt;"> OF </font><font style="display: inline;font-weight:bold;font-size:11pt;">THE SECURITIES</font><font style="display: inline;font-weight:bold;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;">Description of Capital Stock </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">The Company is authorized to issue up to 75,</font><font style="display: inline;">000,000 shares of common s</font><font style="display: inline;">tock</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">and 5,000,000 shares of preferred s</font><font style="display: inline;">tock</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">The following summary is qualified in its entirety by reference to the Company&#x2019;s Amended and Restated Articles of Incorporation (the &#x201C;Articles of Incorporation&#x201D;), the Company&#x2019;s Amended and Restated Bylaws (the &#x201C;Bylaws&#x201D;) and the Florida Business Corporation Act (the &#x201C;FBCA&#x201D;). </font>
		</p>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;">Common Stock </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Holders of common s</font><font style="display: inline;">tock are ent</font><font style="display: inline;">itled to one vote per share of common s</font><font style="display: inline;">tock held of record on all matters to be voted upon by the Company&#x2019;s shar</font><font style="display: inline;">eholders generally. Holders of common s</font><font style="display: inline;">tock are not entitled to cumulative voting rights. </font><font style="display: inline;">As a result, the holders </font><font style="display: inline;">of a majority of the shares of common s</font><font style="display: inline;">tock voting for the election of directors may elect all of the Company&#x2019;s directors if they choose to do so, and, in such event, the hold</font><font style="display: inline;">ers of the remaining shares of common s</font><font style="display: inline;">tock will not be able to elect any person or persons to the Board of Directors. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Holders of common s</font><font style="display: inline;">tock are entitled to receive, on a pro rata basis, such dividends and distributions, if any, as may be declared from time to time by the Board of Directors out of funds legally available therefor, subject to any preferential dividend right of any issued and outstanding </font><font style="display: inline;">shares of preferred s</font><font style="display: inline;">tock. In the event</font><font style="display: inline;"> of liquidation, dissolution or winding up of the Company, after pa</font><font style="display: inline;">yment of creditors, holders of common s</font><font style="display: inline;">tock are entitled to share ratably in all assets</font><font style="display: inline;"> of the Company,</font><font style="display: inline;"> subject to the payment of any </font><font style="display: inline;">liquidation preference of any is</font><font style="display: inline;">sued and outstanding shares of preferred s</font><font style="display: inline;">tock. </font><font style="display: inline;">Furthermore, holders of common s</font><font style="display: inline;">tock have no conversion, sinking fund or redemption rights, or preemptive rights to subscribe for any of </font><font style="display: inline;">the Company&#x2019;s</font><font style="display: inline;"> securities. The shares of common s</font><font style="display: inline;">tock currently outstanding are validly issued, fully paid and non-assessable.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">5</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;">Preferred Stock </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">The Board of Directors of the Company is empowered, without approval of the Company&#x2019;s sh</font><font style="display: inline;">areholders, to cause shares of preferred s</font><font style="display: inline;">tock to be issued in one or more series and to fix and determine the relative rights and preferences of the shares of any such series, subject to the </font><font style="display: inline;">limitations</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">of the FBCA. Because the Board of Directors has the power to establish the preferences and rights of each series, it may affor</font><font style="display: inline;">d the holders of any series of preferred s</font><font style="display: inline;">tock </font><font style="display: inline;">rights </font><font style="display: inline;">and</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">preferences</font><font style="display: inline;">, voting or otherwise, senior to</font><font style="display: inline;"> the rights of holders of common s</font><font style="display: inline;">tock. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">While providing desirable flexibility for possible acquisitions and other corporate purposes, and eliminating delays associated with a shareholder vote on speci</font><font style="display: inline;">fic issuances, the issuance of preferred s</font><font style="display: inline;">tock could adversely affect the voting</font><font style="display: inline;">, dividend and liquidation rights of </font><font style="display: inline;">holders of </font><font style="display: inline;">c</font><font style="display: inline;">ommon </font><font style="display: inline;">s</font><font style="display: inline;">tock. </font>
		</p>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;">Articles of Incorporation and Bylaws </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Certain provisions of the Articles of Incorporation and Bylaws of the Company and of Florida law, which are summarized below, could have the effect of making </font><font style="display: inline;">it more difficult to change the composition of the Company&#x2019;s Board of Directors</font><font style="display: inline;"> or for any person or entity to acquire control of the Company.</font>
		</p>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;">Special Meetings </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Pursuant to</font><font style="display: inline;"> Florida law,</font><font style="display: inline;"> the Company&#x2019;s Articles of Incorporation and Bylaws, special meetings of the shareholders may be called only by </font><font style="display: inline;">the Board of Directors, </font><font style="display: inline;">the President or Secretary at the request in writing of a majority of the Board of Directors then in office or at the request in writing of shareholders owning not less than 50% of all votes entitled to be cast at the special meeting. </font><font style="display: inline;">Only business within the purpose or purposes described in the special meeting notice may be conducted at the special meeting. </font>
		</p>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;">Prohibition of Shareholder Action Without Meeting </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Under the Company&#x2019;s Articles of Incorporation, the shareholders may not take action by written consent. Any and all action by the shareholders is required to be taken at the annual shareholders&#x2019; meeting or at a special shareholders&#x2019; meeting. </font>
		</p>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;">Effect of Florida </font><font style="display: inline;font-weight:bold;">Affiliated Transactions and </font><font style="display: inline;font-weight:bold;">Anti-Takeover Statute</font><font style="display: inline;font-weight:bold;">s</font><font style="display: inline;font-weight:bold;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">The Company is subject to FBCA </font><font style="display: inline;">Section&nbsp;607.0901, which</font><font style="display: inline;"> provides that, subject to certain exceptions, an &#x201C;affiliated transaction&#x201D; must be approved by the holders of two-thirds of the voting shares other than those beneficially owned by an &#x201C;interested shareholder</font><font style="display: inline;">.</font><font style="display: inline;">&#x201D; &nbsp;</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">The Company is also subject to FBCA Section 607.0902, which requires </font><font style="display: inline;">that any </font><font style="display: inline;">person</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">that </font><font style="display: inline;">engages in a </font><font style="display: inline;">&#x201C;</font><font style="display: inline;">control-share acquisition</font><font style="display: inline;">&#x201D; must</font><font style="display: inline;"> obtain </font><font style="display: inline;">approval by a majority of the outstanding shares of each class or series entitled to vote, voting together as a single class, as well as, in some circumstances, a majority of the outstanding shares of any series or class voting as a separate class, </font><font style="display: inline;">before the</font><font style="display: inline;"> acquiring</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">person</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">obtains voting rights for </font><font style="display: inline;">the acquired shares. </font><font style="display: inline;">Although Florida law permits a corporation to opt out of these requirements, t</font><font style="display: inline;">he Company has not elected to opt out, which may have the effect of making it more difficult for any person or group to acquire the Company or substantial amounts </font><font style="display: inline;">of the Company&#x2019;s common s</font><font style="display: inline;">tock</font><font style="display: inline;">, or engage in any &#x201C;affiliated transaction,&#x201D; including the acquisition of a substantial amount of the Company&#x2019;s assets</font><font style="display: inline;">. &nbsp;</font>
		</p>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">6</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:18pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;">Ability to Consider Other Constituencies </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">The directors of the Company are subject to the &#x201C;general standards for directors&#x201D; provisions set forth in Section&nbsp;607.0830 of the FBCA. These provisions provide that, among other things, in discharging his or her duties and determining what is in the best interests of the Company, a director may consider such factors as the director deems relevant, including the long-term prospects and interests of the Company and its shareholders, and the social, economic, legal or other effects of any proposed action on the employees, suppliers or customers of the Company</font><font style="display: inline;"> or its subsidiaries</font><font style="display: inline;">, the communities </font><font style="display: inline;">and society </font><font style="display: inline;">in which the Company </font><font style="display: inline;">or its subsidiaries </font><font style="display: inline;">operate</font><font style="display: inline;">,</font><font style="display: inline;"> and the economy </font><font style="display: inline;">of the state and the nation</font><font style="display: inline;">. Consequently, in connection with any proposed corporate action, the Board of Directors is empowered to consider interests of other constituencies in addition to the interests of the Company&#x2019;s shareholders. Shareholders should be aware that directors who take into account these other factors may make decisions which are less beneficial to the shareholders than if the law did not permit consideration of such other factors. </font>
		</p>
		<p style="margin:18pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">Shareholder Action </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Except as otherwise provided by law or in our Articles of Incorporation or Bylaws, the approval by holders of a majority of the shares of common stock present in person or represented by proxy at a meeting and entitled to vote is sufficient to authorize, affirm, ratify or consent to a matter voted on by shareholders. The FBCA requires the approval of the holders of a majority of the outstanding stock entitled to vote for certain extraordinary corporate transactions, such as a merger</font><font style="display: inline;font-size:11pt;">, share exchange, conversion</font><font style="display: inline;font-size:11pt;">, sale of substantially all assets, dissolution or amendment of the articles of incorporation. </font>
		</p>
		<p style="margin:18pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">Transfer Agent and Registrar </font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">The Transf</font><font style="display: inline;font-size:11pt;">er Agent and Registrar for the common s</font><font style="display: inline;font-size:11pt;">tock is American Stock Transfer&nbsp;&amp; Trust Company, LLC. It is located at 6201 15</font><font style="display: inline;font-size:11pt;font-size:6pt;top:-4pt;position:relative;line-height:100%">th</font><font style="display: inline;font-size:11pt;"> Avenue, Brooklyn, NY 11219, and its telephone number is (718)&nbsp;921-8124.</font>
		</p>
		<p style="margin:18pt 0pt 6pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">Listing</font>
		</p>
		<p style="margin:0pt 0pt 5pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">Our common stock is listed on the New York Stock Exchange under the symbol &#x201C;CRY.&#x201D;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">SELLING S</font><font style="display: inline;">HAREHOLDER</font><font style="display: inline;">S</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620915"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The following table, which was prepared based on information supplied to us by the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s, sets forth the name of each of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s, the number of shares of common stock beneficially owned by each of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s and the number of shares to be offered by each of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s pursuant to this prospectus.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> The table also provides information regarding the beneficial ownership of our common stock by each of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s as adjusted to reflect the assumed sale of all of the shares of common stock offered </font><font style="display: inline;color:#000000;">under this prospectus.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> The ownership percentage indicated in the following table is based on </font><font style="display: inline;color:#000000;">33,871,367</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">total outstanding shares of </font><font style="display: inline;color:#000000;">our</font><font style="display: inline;color:#000000;"> common stock and as of </font><font style="display: inline;color:#000000;">March </font><font style="display: inline;color:#000000;">4</font><font style="display: inline;color:#000000;">, 2016</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> We have no preferred stock outstanding.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">We have determined beneficial ownership in accordance with the rules of the SEC.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">7</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 11pt"><font style="display: inline;color:#000000;">named in the table below have sole voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable community property laws.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">In computing the number of shares of common stock beneficially owned by a person and the percentage ownership of that person, we included outstanding shares of common stock subje</font><font style="display: inline;color:#000000;">ct to options, restricted stock </font><font style="display: inline;color:#000000;">or warrants held by that person that are currently exercisable or exercisable within 60 days of </font><font style="display: inline;color:#000000;">March </font><font style="display: inline;color:#000000;">4</font><font style="display: inline;color:#000000;">, 2016</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person.</font>
		</p>
		<p style="margin:0pt 0pt 2pt;line-height:65%;text-indent:0pt;text-decoration:underline;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:496.80pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:172.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:normal;text-indent:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:64.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:64.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:64.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:64.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:129.85pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Shares Beneficially Owned Prior to the Offering</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Number of Shares Being Registered for </font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:129.80pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Shares Beneficially Owned After the Offering</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 3pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Percentage</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Resale</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Shares(</font><font style="display: inline;font-weight:bold;font-size:8pt;">4</font><font style="display: inline;font-weight:bold;font-size:8pt;">)</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Percentage</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Name of Selling S</font><font style="display: inline;font-size:9pt;">hareholder</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:9pt;">Paul Royalty Fund, L.P.</font><font style="display: inline;font-size:9pt;">(1)**</font>.................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2,648,184&nbsp;
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">7.9%&nbsp;
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2,648,184&nbsp;
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2,648,184&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">7.8%&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:9pt;">PTV Sciences II, L.P</font><font style="display: inline;font-size:9pt;">.(2)</font><font style="display: inline;font-size:9pt;">.</font>.......................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">872,810&nbsp;
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2.6%&nbsp;
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">872,810&nbsp;
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">872,810&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2.6%&nbsp;
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:9pt;">Alpha Medical, Inc.</font><font style="display: inline;font-size:9pt;">(3)</font>...........................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">151,287&nbsp;
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">151,287&nbsp;
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">151,287&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:9pt;">Nancy S. Lewis</font>.....................................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">14,546&nbsp;
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">14,546&nbsp;
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">14,546&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:9pt;">Richard Lynn Alexander</font>.........................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">11,637&nbsp;
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">11,637&nbsp;
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">11,637&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:9pt;">Kevin G. McMahon</font>.............................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2,909&nbsp;
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2,909&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">2,909&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:9pt;">H.A. Lawhon</font>.......................................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">1,745&nbsp;
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">1,745&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.65pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">1,745&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.65pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:172.25pt;background-color: #auto;height:3.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;font-size:9pt;">Thomas J. Madsen</font>...............................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.50pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">581&nbsp;
				</td>
				<td valign="bottom" style="width:64.95pt;background-color: #auto;height:3.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
				<td valign="bottom" style="width:64.90pt;background-color: #auto;height:3.50pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">581&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.50pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">581&nbsp;
				</td>
				<td valign="top" style="width:64.90pt;background-color: #auto;height:3.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 2pt;line-height:65%;text-indent:0pt;text-decoration:underline;font-family:Times New Roman;font-size: 11pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:106pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;"></font></font>
		</p>
		<p style="margin:12pt 0pt 0pt 18pt;border-bottom:1pt none #D9D9D9 ;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:12pt;"><font style="display: inline;font-size:9pt;">*</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:9pt;">Represents less than 1% of the total aggregate amount of shares of our common stock</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt 18pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:10pt;"><font style="display: inline;font-size:9pt;">**</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:9pt;">See the </font><font style="display: inline;font-size:9pt;">Schedule 13</font><font style="display: inline;font-size:9pt;">G filed with the Securities and Exchange Commission on January 28, 2016 by Paul Royalty Fund, L.P., Paul Capital Management LLC and Paul Capital Advisors, L.L.C </font></font>
		</p>
		<p style="margin:12pt 0pt 0pt 18pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:13pt;"><font style="display: inline;font-size:9pt;">(</font><font style="display: inline;font-size:9pt;">1</font><font style="display: inline;font-size:9pt;">)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:9pt;"></font><font style="display: inline;font-size:9pt;">All shares are held of record by </font><font style="display: inline;font-size:9pt;">Paul Royalty Fund, L.P</font><font style="display: inline;font-size:9pt;">. &nbsp;</font><font style="display: inline;font-size:9pt;">Paul Capital Advisors, L.L.C</font><font style="display: inline;font-size:9pt;">.</font><font style="display: inline;font-size:9pt;"> is the manager of </font><font style="display: inline;font-size:9pt;">P</font><font style="display: inline;font-size:9pt;">aul </font><font style="display: inline;font-size:9pt;">C</font><font style="display: inline;font-size:9pt;">apital </font><font style="display: inline;font-size:9pt;">M</font><font style="display: inline;font-size:9pt;">anagement LLC</font><font style="display: inline;font-size:9pt;">, the general partner of </font><font style="display: inline;font-size:9pt;">Paul Royalty Fund, L.P.</font><font style="display: inline;font-size:9pt;">&nbsp;</font><font style="display: inline;font-size:9pt;">Paul Capital Advisors, L.L.C</font><font style="display: inline;font-size:9pt;">. and </font><font style="display: inline;font-size:9pt;">Paul Capital Management LLC </font><font style="display: inline;font-size:9pt;">share voting and dispositive power over the shares held by </font><font style="display: inline;font-size:9pt;">Paul Royalty Fund, L.P</font><font style="display: inline;font-size:9pt;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt 18pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:7pt;"><font style="display: inline;font-size:9pt;">(2) </font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:9pt;"></font><font style="display: inline;font-size:9pt;">All shares are held of record by PTV Sciences II, L.P.</font><font style="display: inline;font-size:9pt;">&nbsp;</font><font style="display: inline;font-size:9pt;">Pinto TV GP Company LLC is the general partner of </font><font style="display: inline;font-size:9pt;">Pinto Technology </font><font style="display: inline;font-size:9pt;">Ventures GP II, L.P., </font><font style="display: inline;font-size:9pt;">the general </font><font style="display: inline;font-size:9pt;">partner of PTV Sciences II, L.P</font><font style="display: inline;font-size:9pt;">. &nbsp;</font><font style="display: inline;font-size:9pt;"> Matthew S. </font><font style="display: inline;font-size:9pt;">Crawford and </font><font style="display: inline;font-size:9pt;">Rick D. </font><font style="display: inline;font-size:9pt;">Anderson </font><font style="display: inline;font-size:9pt;">are</font><font style="display: inline;font-size:9pt;"> manager</font><font style="display: inline;font-size:9pt;">s</font><font style="display: inline;font-size:9pt;"> of </font><font style="display: inline;font-size:9pt;">Pinto TV GP Company LLC </font><font style="display: inline;font-size:9pt;">and are</font><font style="display: inline;font-size:9pt;"> deemed to </font><font style="display: inline;font-size:9pt;">share voting and dispositive power over </font><font style="display: inline;font-size:9pt;">the shares held by </font><font style="display: inline;font-size:9pt;">PTV Sciences II, L.P. </font></font>
		</p>
		<p style="margin:12pt 0pt 0pt 18pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:8pt;"><font style="display: inline;font-size:9pt;">(3)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:9pt;"></font><font style="display: inline;font-size:9pt;">All shares are held of record by </font><font style="display: inline;font-size:9pt;">Alpha Medical, Inc. </font><font style="display: inline;font-size:9pt;">Rudiger </font><font style="display: inline;font-size:9pt;">Dahle </font><font style="display: inline;font-size:9pt;">founded Alpha Medical, Inc. in 1993 and is the sole shareholder. </font><font style="display: inline;font-size:9pt;">Mr. Dahle</font><font style="display: inline;font-size:9pt;"> has sole voting power over all of the shares</font><font style="display: inline;font-size:9pt;"> of Alpha Medical, Inc.</font><font style="display: inline;font-size:9pt;">&nbsp;</font><font style="display: inline;font-size:9pt;">Mr. Dahle</font><font style="display: inline;font-size:9pt;"> is the President and Secretary of Alpha Medical, Inc. </font></font>
		</p>
		<p style="margin:12pt 0pt 0pt 18pt;border-top:1pt none #D9D9D9 ;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:8pt;"><font style="display: inline;font-size:9pt;">(4)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-size:9pt;"></font><font style="display: inline;font-size:9pt;">Assumes the sale of all shares being offered pursuant to this prospectus.</font></font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">PLAN OF DISTRIBUTION</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620916"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12.15pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">We are registering pursuant to this prospectus a total of </font><font style="display: inline;color:#000000;">3,703,</font><font style="display: inline;color:#000000;">699</font><font style="display: inline;color:#000000;"> shares of common stock on behalf of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s. The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s, which as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests in shares of common stock received after the date of this prospectus from a selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;"> as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.</font>
		</p>
		<p style="margin:12pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">8</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;color:#000000;">The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s may use any one or more of the following methods when disposing of shares or interests therein:</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">sales on the NYSE or any national securities exchange or quotation service on which our common stock may be listed or quoted at the time of sale;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">purchases by a broker-dealer as principal and resale by the broker-dealer for its&nbsp;&nbsp;account;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">an exchange distribution in accordance with the rules of the applicable exchange;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">privately negotiated transactions;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">short sales;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">through the writing or settlement of options or oth</font><font style="display: inline;color:#000000;">er hedging transactions, whether </font><font style="display: inline;color:#000000;">through an options exchange or otherwise;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">broker-dealers may agree with the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s to sell a specified number&nbsp;&nbsp;of such shares at a stipulated price per share;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">a combination of any such methods of sale; and</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
				<font style="margin:12pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:6pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:12pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">any other method permitted by applicable law.</font></p></td></tr></table></div>
		<p style="margin:13.65pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">A selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;"> that is an entity may elect to make a pro rata in-kind distribution of the shares of common stock to its members, partners or shareholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus. To the extent that such members, partners or shareholders are not affiliates of ours, such members, partners or shareholders would thereby receive freely tradable shares of common stock pursuant to the distribution through a registration statement.</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable p</font><font style="display: inline;color:#000000;">rovision of the Securities Act, </font><font style="display: inline;color:#000000;">amending the list of selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s to include the pledgee, transferee or other successors in interest as selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s under this prospectus. The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">In connection with the sale of our common stock or interests therein, the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s may also sell shares of our common stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">9</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;font-family:Times New Roman;font-size: 11pt"><font style="display: inline;color:#000000;">dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The aggregate proceeds to the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s from the sale of the common stock offered by them will be the purchase price of the common stock less discounts or commissions, if any. Each of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not receive any of the proceeds from this offering.</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet the criteria and conform to the requirements of that rule.</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be &#x201C;underwriters&#x201D; within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s who are &#x201C;underwriters&#x201D; within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act.</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">To the extent required, the shares of our common stock to be sold, the names of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s, the respective purchase prices and public offering prices, the names of any agents, dealers or underwriters and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.</font>
		</p>
		<p style="margin:0pt 7.2pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 7.2pt;text-indent:28.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">In order to comply with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers.</font>
		</p>
		<p style="margin:0pt 7.2pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 7.2pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">We have advised the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s that the anti-manipulation rules of Regulation M under the Exchange Act, as amended, may apply to sales of shares in the market and to the activities of the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s and their affiliates. In addition, to the extent applicable we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Pursuant to, and in accordance with the terms of, the Registration Rights Agreement (i) we have agreed to indemnify the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s (and their respective officers, directors, agents, partners, members, managers and employees, and each other person, if any, who controls such selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s (within the meaning of the Securities Act)), against certain liabilities, including liabilities under the Securities Act, relating to the registration of the shares offered by this prospectus, or the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s may be entitled to contribution if indemnification is prohibited by law, and (ii) the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s have agreed to indemnify us (including our directors, officers, employees, s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s and each person who controls the Company (within the meaning of the Securities Act)) against certain liabilities, including liabilities under the Securities Act that may arise from any written information furnished to us by the selling </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">10</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;font-family:Times New Roman;font-size: 11pt"><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s for use in this prospectus or the registration statement that includes this prospectus, or we may be entitled to contribution if indemnification is prohibited by law.</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Pursuant to the Registration Rights Agreement, we have agreed with the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s to keep the registration statement of which this prospectus constitutes a part effective until the </font><font style="display: inline;color:#000000;">earlie</font><font style="display: inline;color:#000000;">r</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">of (i) </font><font style="display: inline;color:#000000;">October 16, 2016</font><font style="display: inline;color:#000000;">, and (ii) such time as the Registrable Securities covered by this Registration Statement have been sold pursuant to (x) this Registration Statement or (y) Rule 144 under the Securities Act or otherwise.</font>
		</p>
		<p style="margin:11.9pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Broker-dealers and agents, and their respective affiliates, may be engaged in transactions with, or perform commercial or investment banking or other services for, us or our subsidiaries or affiliates, in the ordinary course of business.</font>
		</p>
		<p style="margin:0pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The selling shareholders and any permitted transferee(s) selling shares under this prospectus will act independently of us in making decisions with respect to the timing, manner, and size of each resale. There can be no assurance that the selling shareholders and any permitted transferee(s) will sell any or all of the shares under this prospectus. Further, we cannot assure you that the selling shareholders and any permitted transferee(s) will not transfer, distribute, devise or gift the shares by other means not described in this prospectus, including through dividends or other distributions made by the selling shareholders or permitted transferees on a private placement basis to their respective partners, members or s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s. In addition, any shares covered by this prospectus that qualify for sale under Rule 144 of the Securities Act may be sold under Rule 144 rather than under this prospectus.</font>
		</p>
		<p style="margin:0pt 7.2pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 7.2pt 0pt 0pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Pursuant to the Merger </font><font style="display: inline;color:#000000;">Agreement </font><font style="display: inline;color:#000000;">and a Lockup Agreement delivered by PTV Sciences II, L.P. and Paul Royalty Fund, L.P. to </font><font style="display: inline;color:#000000;">us</font><font style="display: inline;color:#000000;"> upon the </font><font style="display: inline;color:#000000;">c</font><font style="display: inline;color:#000000;">losing of the </font><font style="display: inline;color:#000000;">m</font><font style="display: inline;color:#000000;">erger, PTV Sciences II, L.P. and Paul Royalty Fund, L.P. and certain of their permitted transferees are subject to a lock-up for a period of 90 days following </font><font style="display: inline;color:#000000;">January 20</font><font style="display: inline;color:#000000;">, 2016</font><font style="display: inline;color:#000000;"> and ending on </font><font style="display: inline;color:#000000;">April 19, 2016</font><font style="display: inline;color:#000000;">.&nbsp;&nbsp;During this period, subject to certain exceptions, they may not, directly or indirectly, without </font><font style="display: inline;color:#000000;">our</font><font style="display: inline;color:#000000;"> prior written consent, offer, pledge, sell, contract to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock acquired in the </font><font style="display: inline;color:#000000;">m</font><font style="display: inline;color:#000000;">erger or any securities convertible into or exercisable or exchangeable for shares of our common stock, enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the shares, whether any such transaction described above is to be settled by delivery of shares of our common stock, in cash or otherwise, or publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to any shares of our common stock acquired in the </font><font style="display: inline;color:#000000;">m</font><font style="display: inline;color:#000000;">erger. The lock-up provisions permit transferring the </font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">hares in connection with:</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:6pt 7.2pt 0pt 0pt;">
				<font style="margin:6pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:8pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:6pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">a sale of CryoLife approved by its board of directors or a tender offer or exchange offer for all of the outstanding shares of CryoLife&#x2019;s common stock;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 7.2pt 0pt 0pt;">
				<font style="margin:0pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:8pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">transfers as a </font><font style="display: inline;font-style:italic;color:#000000;">bona fide </font><font style="display: inline;color:#000000;">gift, by will or intestacy or to a family member or trust for the benefit of certain family members;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 7.2pt 0pt 0pt;">
				<font style="margin:0pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:8pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">transfers to a charity or educational institution; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 7.2pt 0pt 0pt;">
				<font style="margin:0pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:8pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;border-bottom:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">if the Investor is a corporation, partnership, limited liability company or other business entity, any transfers to any shareholder, partner or member of, or owner of similar equity interests in, the Investor, subject to certain limitations; or</font></p></td></tr></table></div>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">11</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 7.2pt 0pt 0pt;">
				<font style="margin:0pt 7.2pt 0pt 0pt;font-family:Symbol;font-size:8pt;line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9;color:#000000;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:13.8pt;text-align:justify;text-justify:inter-ideograph;vertical-align:baseline;border-top:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 7.2pt 0pt 0pt;">
			<font style="display: inline;color:#000000;">transfers between other former holders of On-X Life Technologies, Inc. capital stock that have also executed a substantially similar lock-up agreement.</font></p></td></tr></table></div>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">12</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;color:#000000;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">LEGAL MATTERS</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The validity of the shares of common stock offered by this prospectus has been passed upon for </font><font style="display: inline;color:#000000;">CryoLife</font><font style="display: inline;color:#000000;"> by </font><font style="display: inline;color:#000000;">Shutts &amp; Bowen LLP</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font>
		</p>
		<p style="margin:24pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">EXPERTS</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="color:#008000;display: inline;color:#000000;">The consolidated financial statements of CryoLife, Inc. appearing in CryoLife, Inc.&#x2019;s Annual Report (Form 10-K) for the year ended December 31, 2015, and the effectiveness of CryoLife, Inc.&#x2019;s internal control over financial reporting as of December 31, 2015 have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The</font><font style="display: inline;color:#000000;"> consolidated</font><font style="display: inline;color:#000000;"> financial statements of</font><font style="display: inline;color:#000000;"> On-X Life Technologies Holdings</font><font style="display: inline;color:#000000;">, Inc. included in Exhibit 99.1 of </font><font style="display: inline;color:#000000;">CryoLife</font><font style="display: inline;color:#000000;">&#x2019;s Current Report on Form 8-K/A </font><font style="display: inline;color:#000000;">filed with the SEC on</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">March</font><font style="display: inline;color:#000000;"> &nbsp;9</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;">2016</font><font style="display: inline;color:#000000;"> have been incorporated</font><font style="display: inline;color:#000000;"> by reference</font><font style="display: inline;color:#000000;"> in this prospectus in reliance on the report of </font><font style="display: inline;color:#000000;">KPMG LLP,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">an independent registered public accounting firm, </font><font style="display: inline;color:#000000;">and the report of Padgett Stratemann &amp; Co., </font><font style="display: inline;color:#000000;">LLP </font><font style="display: inline;color:#000000;">an independent registered public accounting firm, and </font><font style="display: inline;color:#000000;">up</font><font style="display: inline;color:#000000;">on the authority of said firm</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> as experts in </font><font style="display: inline;color:#000000;">accounting and auditing</font><font style="display: inline;color:#000000;">.</font>
		</p>
		<p style="margin:24pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">INFORMATION INCORPORATED BY REFERENCE</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620919"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The SEC allows us to &#x201C;incorporate by reference&#x201D; the information we file with them, which means that we can disclose important information to you by referring you to those documents.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> The information incorporated by reference is considered to be part of this prospectus, and information that we file later with the SEC will automatically update and supersede information included or previously incorporated by reference in this prospectus from the date we file the document containing such information.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Except to the extent furnished and not filed with the </font><font style="display: inline;color:#000000;">SEC</font><font style="display: inline;color:#000000;"> pursuant to Item</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">2.02 or Item</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">7.01 of Form 8-K or as otherwise permitted by the </font><font style="display: inline;color:#000000;">SEC rules, we incorporate by reference the </font><font style="display: inline;color:#000000;">documents listed below and any future filings we </font><font style="display: inline;color:#000000;">may file</font><font style="display: inline;color:#000000;"> with the SEC under Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act, </font><font style="display: inline;color:#000000;">prior to</font><font style="display: inline;color:#000000;"> the completion of the offering in the relevant prospectus supplement to which this prospectus relates or the termination of the offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, but excluding any information deemed furnished and not filed with the SEC.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Any statements contained in a previously filed document incorporated by reference into this </font><font style="display: inline;color:#000000;">prospectus is deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus, or in a subsequently filed document also incorporated by reference herein, modifies or supersedes that statement. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The documents we incorporate by reference into this prospectus are:</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">1. Our Annual Report on Form 10-K for the year ended December&nbsp;31, </font><font style="display: inline;color:#000000;">201</font><font style="display: inline;color:#000000;">5</font><font style="display: inline;color:#000000;">, filed with the SEC on </font><font style="display: inline;color:#000000;">February 16,</font><font style="display: inline;color:#000000;"> 201</font><font style="display: inline;color:#000000;">6</font><font style="display: inline;color:#000000;">;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">13</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;color:#000000;">2</font><font style="display: inline;color:#000000;">. Our </font><font style="display: inline;color:#000000;">Current Report</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> on Form 8-K, </font><font style="display: inline;color:#000000;">but only to the extent that the information set forth therein is </font><font style="display: inline;color:#000000;">&#x201C;filed&#x201D; rather than &#x201C;furnished&#x201D; under the SEC</font><font style="display: inline;color:#000000;"> rules, filed </font><font style="display: inline;color:#000000;">with the SEC </font><font style="display: inline;color:#000000;">on</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">January </font><font style="display: inline;color:#000000;">25, 2016</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;">February 8, 2016</font><font style="display: inline;color:#000000;">, March 1, 2016 and March </font><font style="display: inline;color:#000000;">9</font><font style="display: inline;color:#000000;">, 2016</font><font style="display: inline;color:#000000;">; and</font><font style="display: inline;color:#000000;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">3</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">The description of our common stock contained in our registration statement on Form 8-A, filed on July 2, 1997, and any amendment or report filed for the purpose of updating such description, including without limitation, our Amendment No. 1 to Form 8-A/A filed on November 3, 2005.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">This prospectus is part of a registration statement on Form S-3 filed with the </font><font style="display: inline;color:#000000;">SEC under the Securities Act.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> This prospectus does not contain all of the information set forth in the registration statement</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> You should read the registration statement for further information about </font><font style="display: inline;color:#000000;">CryoL</font><font style="display: inline;color:#000000;">ife</font><font style="display: inline;color:#000000;"> and our common stock.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Documents incorporated by reference are available from us, without charge, excluding all exhibits unless specifically incorporated by reference in the documents.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> You may obtain documents incorporated by reference in this prospectus by writing to us at the following address or by calling us at the telephone number listed below:</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">CryoLife, Inc. </font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Attn: Secretary </font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">1655 Roberts Boulevard, NW </font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">Kennesaw, Georgia 30144 </font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">(770) 419-3355</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">You should rely only on the information incorporated by reference or provided in this prospectus or any prospectus supplement.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> We have not authorized anyone else to provide you with different information.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any date other than the date on the front page of those documents.</font>
		</p>
		<p style="margin:24pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><a name="_Toc444620920"></a><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font><font style="display: inline;font-weight:normal;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">We file annual, quarterly and special reports, proxy statements and other information with the SEC.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> You may read and copy any document we file at the SEC&#x2019;s Public Reference Room located at 100 F Street, N.E.</font><font style="display: inline;color:#000000;">, Washing</font><font style="display: inline;color:#000000;">ton</font><font style="display: inline;color:#000000;">, D.C. 20549.</font><font style="display: inline;color:#000000;"> Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Our SEC filings are also available to the public over the internet from the SEC&#x2019;s website at www.sec.gov, or our website at </font><font style="display: inline;color:#000000;">www.cryolife.com</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> The contents of our website are not incorporated by reference in or otherwise a part of this prospectus.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:54pt;">
		<p style="margin:12pt 0pt 0pt;border-top:5pt double #000000 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">14</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">-</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;border-top:5pt double #000000 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-size:14pt;">CRYOLIFE, INC.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 16pt">
			<font style="display: inline;font-size:16pt;">Common Stock</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p>
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-size:14pt;">PROSPECTUS</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p>
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:5pt double #000000 ;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:54pt;">
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;">PART II</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">INFORMATION NOT REQUIRED IN PROSPECTUS</font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-weight:bold;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">ITEM</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The following table sets forth the estimated costs and expenses payable by the registrant in connection with the </font><font style="display: inline;color:#000000;">registration and distribution</font><font style="display: inline;color:#000000;"> of the securities being registered.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">The selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s are responsible for any expenses incurred by them for brokerage, tax or other legal services incurred by the selling s</font><font style="display: inline;color:#000000;">hareholder</font><font style="display: inline;color:#000000;">s in disposing of securities held by them, as well as any underwriting discount or commissions</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> All of the amounts shown are estimates except the SEC registration fee.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:496.80pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:421.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:74.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:421.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 3pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:74.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Amount</font><br /><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">to be Paid</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:421.90pt;background-color: #auto;height:12.60pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 10pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">SEC registration fee</font>.....................................................................................................................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font></font></p>
				</td>
				<td valign="top" style="width:74.90pt;background-color: #auto;height:12.60pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:1.1pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-size:10pt;">4,154.81</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:421.90pt;background-color: #auto;height:13.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 10pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">Printing fees</font>...............................................................................................................................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font></font></p>
				</td>
				<td valign="top" style="width:74.90pt;background-color: #auto;height:13.50pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:1.1pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-size:10pt;">0</font><font style="display: inline;font-size:10pt;">.00</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:421.90pt;background-color: #auto;height:13.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 10pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">Legal fees and expenses</font>...............................................................................................................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font></font></p>
				</td>
				<td valign="top" style="width:74.90pt;background-color: #auto;height:13.50pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;"> &nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-size:10pt;">33,800.00</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:421.90pt;background-color: #auto;height:13.50pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 10pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">Accounting fees and expenses</font>.......................................................................................................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font></font></p>
				</td>
				<td valign="top" style="width:74.90pt;background-color: #auto;height:13.50pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;border-bottom:1pt solid #000000 ;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;"> &nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-size:10pt;">21,000</font><font style="display: inline;font-size:10pt;">.00</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:421.90pt;background-color: #auto;height:19.10pt;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt;text-indent: -10.8pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:74.90pt;background-color: #auto;height:19.10pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:421.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:0pt 10.8pt 0pt 21.6pt;text-indent: -10.8pt;font-family:Times New Roman;font-size: 10pt">
						<font style="text-indent:0pt;margin-left:-1.8pt; overflow: hidden; white-space: nowrap;"><font style="display: inline;">Total</font>...........................................................................................................................................................</font><font style="text-indent:0pt;margin-left:0pt;text-align:right"><font style="display: inline;"></font></font></p>
				</td>
				<td valign="top" style="width:74.90pt;background-color: #auto;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;border-bottom:2pt double #000000 ;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">$</font><font style="display: inline;font-size:10pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font style="display: inline;font-size:10pt;">58,954.81</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-weight:bold;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">ITEM</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">15. INDEMNIFICATION OF DIRECTORS AND OFFICERS.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The r</font><font style="display: inline;color:#000000;">egistrant is a Florida corporation.&nbsp; </font><font style="display: inline;color:#000000;">Under Section 607.0850(1) of </font><font style="display: inline;color:#000000;">the Florida Business Corporation Act (the &#x201C;</font><font style="display: inline;color:#000000;">FBCA&#x201D;)</font><font style="display: inline;color:#000000;">, a corporation may indemnify any of its directors and </font><font style="display: inline;color:#000000;">officers against judgments, penalties, fines, amounts paid in settlement, and expenses (including attorneys&#x2019; fees) actually and reasonably incurred by such person in connection with such action, suit or proceeding (including any appeal thereof) (i) if such person</font><font style="display: inline;color:#000000;"> acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation, and (ii) with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct was </font><font style="display: inline;color:#000000;">unlawful.&nbsp;&nbsp;In actions brought by or in the right of the corporation, however, Section 607.0850(2) provides that no indemnification shall be made in respect of any claim, issue or matter as to which the director or officer shall have been adjudged to be liable unless, and only to the extent that, the court in which such proceeding was brought, or any other court of competent jurisdiction, shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper.&nbsp; </font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Article </font><font style="display: inline;color:#000000;">VII</font><font style="display: inline;color:#000000;"> of the registrant&#x2019;s Amended and Restated Articles of Incorporation </font><font style="display: inline;color:#000000;">require</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> that, if in the judgment of the majority of the Board of Directors (excluding from such majority any director under consideration for indemnification)</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> the criteria set forth under Section</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> 607.0850</font><font style="display: inline;color:#000000;">(1) and (2)</font><font style="display: inline;color:#000000;"> have been met, then the registrant shall indemnify its directors and officers in the manner and to the extent </font><font style="display: inline;color:#000000;">contemplated b</font><font style="display: inline;color:#000000;">y Sections 607.0850(1) and (2) of the FBCA</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">The registrant&#x2019;s Amended and Restated Bylaws also state that the rights to indemnification are binding contract rights which are binding on the registrant with respect to any conduct that takes place while the provision remains in place, even if the provision is later amended, and that the rights continue as to a person who has ceased to be an officer or director.&nbsp;&nbsp;Expenses, including reasonable attorneys&#x2019; fees, paralegals&#x2019; fees and court costs, incurred by a director or officer in defending a proceeding for </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">II-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">1</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 11pt"><font style="display: inline;color:#000000;">which indemnification is provided will be paid by the registrant in advance of the final disposition of such proceeding provided that the director or officer represents that he or she has met the applicable standard of conduct in relation to the proceeding and will repay such amount if he or she is ultimately found not to be entitled to indemnification.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The registrant has purchased insurance to insure (i) the registrant&#x2019;s directors and officers against damages from actions and claims incurred in the course of their duties, and (ii) the registrant against expenses incurred in defending lawsuits arising from certain alleged acts of its directors and officers.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The r</font><font style="display: inline;color:#000000;">egistrant has also </font><font style="display: inline;color:#000000;">entered into indemnification agreements with each of its directors and its </font><font style="display: inline;color:#000000;">Executive Vice Pre</font><font style="display: inline;color:#000000;">sident, Chief Operating Officer, </font><font style="display: inline;color:#000000;">Chief Financial Officer</font><font style="display: inline;color:#000000;"> and Treasurer</font><font style="display: inline;color:#000000;"> (&#x201C;Indemnitees&#x201D;).</font><font style="display: inline;color:#000000;"> &nbsp; </font><font style="display: inline;color:#000000;">Pursuant to such agreements, </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">registrant shall</font><font style="display: inline;color:#000000;"> indemnify </font><font style="display: inline;color:#000000;">the Indemnitees to the fully extent permitted by the FBCA. The agreements further provide that u</font><font style="display: inline;color:#000000;">nless a determination has been made that </font><font style="display: inline;color:#000000;">an</font><font style="display: inline;color:#000000;"> Indemnitee is not entitled to indemnification pursuant to </font><font style="display: inline;color:#000000;">such Indemnitee&#x2019;s</font><font style="display: inline;color:#000000;"> agreement, all reasonable expenses incurred by or on behalf of such Indemnitee will be advanced from time to time by the Company to the Indemnitee within twenty (20) days after the Company&#x2019;s receipt of a written request for an advance of expenses by such Indemnitee, whether prior to or after final disposition of a proceeding.&nbsp;&nbsp;The Indemnitee must agree, at the time of such advance, to repay the amounts advanced if it is ultimately determined that such Indemnitee is not entitled to be indemnified under the terms of the agreement. Any advances made will be unsecured, and no interest will be charged on such advances</font><font style="display: inline;color:#000000;">.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-weight:bold;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">ITEM</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">16. EXHIBITS.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">The following exhibits are included herein or incorporated herein by reference:</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:50.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;height:3.50pt;overflow: hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:288.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:3.50pt;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:52.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:3.50pt;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:52.55pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:3.50pt;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:52.55pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:3.50pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:3.50pt;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:157.50pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Incorporated by reference herein</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Exhibit Number</font></p>
				</td>
				<td colspan="2" valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Description</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Form</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Date</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Exhibit Number</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2.1*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Agreement and Plan of Merger, dated May 14, 2012, by and among CryoLife, Inc., CL Crown, Inc., Hemosphere, Inc. and a Stockholder Representative.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">10-Q</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">7/31/12</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2.1</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2.2*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Agreement and Plan of Merger, dated as of December 22, 2015, by and among CryoLife, Inc., On-X Life Technologies Holdings, Inc., Cast Acquisition Corporation, Fortis Advisors LLC and each of the security holders who becomes a party thereto.&nbsp;&nbsp;Certain schedules and exhibits referenced in the Agreement and Plan of Merger have been omitted in accordance with Item 601(b)(2) of Regulation&nbsp;S&#x2013;K. A copy of any omitted schedule or exhibit will be furnished supplementally to the Securities and Exchange Commission upon request.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">8-K</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">1/25/16</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2.1</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.1*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Form of Certificate for Common Stock of CryoLife, Inc.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">10-K</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2/19/98</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.2</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.2*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Registration Rights Agreement, dated as of January 20, 2016, by and between CryoLife, Inc. and the investors parties thereto.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">8-K</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">1/25/16</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.1</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.3*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Form of Indenture for Senior Debt Securities</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">S-3</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">8/5/15</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.7</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.4*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Form of Subordinated Indenture for Subordinated Debt Securities</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">S-3</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">8/5/15</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.9</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">5.1**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Opinion of Shutts and Bowen LLP</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">23.1**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Consent of Shutts and Bowen LLP (included in Exhibit&nbsp;5.1 to this Registration Statement)</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">23.2**</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.45pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Consent of Ernst&nbsp;&amp; Young LLP</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.70pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">23.3**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Consent of KPMG LLP</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">23.4**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Consent of Padgett Stratemann &amp; Co., LLP</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">24.1**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Power of Attorney (contained in the signature page to this Registration Statement)</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 2pt;line-height:65%;text-indent:0pt;text-decoration:underline;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">II-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">2</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt 0pt 2pt;line-height:65%;text-indent:0pt;text-decoration:underline;font-family:Times New Roman;;font-size: 11pt"><font style="text-indent:0pt;margin-left:0pt; padding-right:106pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;"></font></font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:18pt;">
			<tr>
				<td valign="top" style="width:23.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:23.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
				<td valign="top" style="width:171.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Incorporated by reference herein</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:23.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">**</font></p>
				</td>
				<td valign="top" style="width:171.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Filed herewith</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;font-weight:bold;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;font-weight:bold;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">ITEM 17. UNDERTAKINGS.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(a) The undersigned registrant hereby undertakes:</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:72pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(i) To include any prospectus required by </font><font style="display: inline;color:#000000;">Section&nbsp;</font><font style="display: inline;color:#000000;">10(a)(3) of the Securities Act</font><font style="display: inline;color:#000000;"> of 1933</font><font style="display: inline;color:#000000;">;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to </font><font style="display: inline;color:#000000;">Rule&nbsp;</font><font style="display: inline;color:#000000;">424(b) if, in the aggregate, the changes in volume and price represent no more than </font><font style="display: inline;color:#000000;">20 percent</font><font style="display: inline;color:#000000;"> change in the maximum aggregate offering price set forth in the &#x201C;Calculation of Registration Fee&#x201D; table in the effective registration statement; and</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(iii) To include any material information with respect to the plan of distribution not previously </font><font style="display: inline;color:#000000;">disclosed in the registration statement or any material change to such information in the registration statement; </font><font style="display: inline;color:#000000;text-decoration:underline;">provided</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;text-decoration:underline;">however</font><font style="display: inline;color:#000000;">, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) </font><font style="display: inline;color:#000000;">do not apply if the </font><font style="display: inline;color:#000000;">information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the </font><font style="display: inline;color:#000000;">Securities </font><font style="display: inline;color:#000000;">Exchange Act</font><font style="display: inline;color:#000000;"> of 1934 </font><font style="display: inline;color:#000000;">that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule&nbsp;424(b) that is part of the registration statement.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:72pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(2) That, for the purpose of determining any liability under</font><font style="display: inline;color:#000000;"> the Securities Act</font><font style="display: inline;color:#000000;"> of 1933</font><font style="display: inline;color:#000000;">, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="display: inline;font-style:italic;color:#000000;">bona fide</font><font style="display: inline;color:#000000;"> offering thereof.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:72pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:72pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(4) That, for the purpose of determining liability under the Securities Act</font><font style="display: inline;color:#000000;"> of 1933</font><font style="display: inline;color:#000000;"> to any purchaser:</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(i) Each prospectus filed by the registrant pursuant to Rule&nbsp;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">II-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">3</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;color:#000000;">(ii) Each prospectus required to be filed pursuant to Rule&nbsp;424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule&nbsp;430B relating to an offering made pursuant to Rule&nbsp;415(a)(1)(i), (vii)&nbsp;or (x) for the purpose of providing the information required by Section&nbsp;10(a) of the Securities Act</font><font style="display: inline;color:#000000;"> of 1933</font><font style="display: inline;color:#000000;"> shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;"> As provided in Rule&nbsp;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial </font><font style="display: inline;font-style:italic;color:#000000;">bona fide</font><font style="display: inline;color:#000000;"> offering thereof.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">Provided, however</font><font style="display: inline;color:#000000;">, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to the effective date.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:72pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(5) That, for the purpose of determining liability of the registrant under the Securities Act</font><font style="display: inline;color:#000000;"> of 1933</font><font style="display: inline;color:#000000;"> to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer and sell such securities to such purchaser:</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to </font><font style="display: inline;color:#000000;">Rule&nbsp;</font><font style="display: inline;color:#000000;">424;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned regi</font><font style="display: inline;color:#000000;">strant or used or referred to by</font><font style="display: inline;color:#000000;"> the undersigned registrant;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:108pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act</font><font style="display: inline;color:#000000;"> of 1934</font><font style="display: inline;color:#000000;">, each filing of the registrant&#x2019;s annual report pursuant to </font><font style="display: inline;color:#000000;">Section&nbsp;</font><font style="display: inline;color:#000000;">13(a) or </font><font style="display: inline;color:#000000;">Section&nbsp;</font><font style="display: inline;color:#000000;">15(d) of the</font><font style="display: inline;color:#000000;"> Securities</font><font style="display: inline;color:#000000;"> Exchange Act</font><font style="display: inline;color:#000000;"> of 1934</font><font style="display: inline;color:#000000;"> (and, where applicable, each filing of an employee benefit plan&#x2019;s annual report pursuant to </font><font style="display: inline;color:#000000;">Section&nbsp;</font><font style="display: inline;color:#000000;">15(d) of the </font><font style="display: inline;color:#000000;">Securities </font><font style="display: inline;color:#000000;">Exchange Act</font><font style="display: inline;color:#000000;"> of 1934</font><font style="display: inline;color:#000000;">) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="display: inline;font-style:italic;color:#000000;">bona fide</font><font style="display: inline;color:#000000;"> offering thereof.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">(c) Insofar as indemnification for liabilities arising under the Securities Act </font><font style="display: inline;color:#000000;">of 1933 </font><font style="display: inline;color:#000000;">may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act </font><font style="display: inline;color:#000000;">of 1933 </font><font style="display: inline;color:#000000;">and is, therefore, </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">II-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">4</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 11pt"><font style="display: inline;color:#000000;">unenforceable.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">In the event that</font><font style="display: inline;color:#000000;"> a claim for indemnifi</font><font style="display: inline;color:#000000;">cation against such liabilities</font><font style="display: inline;color:#000000;"> (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of </font><font style="display: inline;color:#000000;">any action, suit or proceeding)</font><font style="display: inline;color:#000000;"> is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act </font><font style="display: inline;color:#000000;">of 1933 </font><font style="display: inline;color:#000000;">and will be governed by the final adjudication of such issue.</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">II-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">5</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 11pt"><font style="display: inline;font-weight:bold;color:#000000;"></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">SIGNATURES</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, </font><font style="display: inline;color:#000000;">in the City of Kennesaw, State of Georgia</font><font style="display: inline;color:#000000;">, on </font><font style="display: inline;color:#000000;">March 9</font><font style="display: inline;color:#000000;">, 2016</font><font style="display: inline;color:#000000;">.</font>
		</p>
		<p style="margin:12pt 0pt 0pt 252pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;">CryoLife, </font><font style="display: inline;font-weight:bold;">Inc.</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:252pt;">
			<tr>
				<td valign="top" style="width:27.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:216.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:27.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">By:</font></p>
				</td>
				<td valign="top" style="width:216.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">/s/ D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:27.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:216.90pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Executive Vice President, Chief Operating</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:27.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:216.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">Officer, Chief Financial Officer and Treasurer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:24pt 0pt 0pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">POWER OF ATTORNEY</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below hereby constitutes and appoints </font><font style="display: inline;color:#000000;">J. Patrick Mackin </font><font style="display: inline;color:#000000;">and </font><font style="display: inline;color:#000000;">D. Ashley Lee</font><font style="display: inline;color:#000000;">, and each of them, as his or her true and lawful attorney in fact and agent with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Registration Statem</font><font style="display: inline;color:#000000;">ent on Form S-3 (including post-</font><font style="display: inline;color:#000000;">effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney in fact, proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney in fact, proxy and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;">Pursuant to the requirements of the Securities Act of 1933, </font><font style="display: inline;color:#000000;">as amended, </font><font style="display: inline;color:#000000;">this Registration Statement on Form S-3 has been signed by the following persons in the capacities and on the dates indicated.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:186.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">/s</font></p>
				</td>
				<td valign="bottom" style="width:206.85pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:104.55pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Signature</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Title</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Date</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ J. Patrick Mackin</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">J. Patrick Mackin </font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Chairman of the Board, Chief Executive Officer, President and Director</font><br /><font style="display: inline;">(Principal Executive Officer)</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ D. Ashley Lee</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">D. Ashley Lee</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Executive Vice Pre</font><font style="display: inline;">sident, Chief Operating Officer, </font><font style="display: inline;">Chief Financial Officer</font><font style="display: inline;"> and Treasurer</font><br /><font style="display: inline;">(Principal Financial Officer)</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ Amy D. Horton</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Amy D. Horton</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Vice President, Chief Accounting Officer</font><br /><font style="display: inline;">(Principal Accounting Officer)</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ Thomas F. Ackerman</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Thomas F. Ackerman</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Director </font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ James S. Benson</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">James S. Benson</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Director</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr></table>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">II-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">6</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ Daniel J. Bevevino</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Daniel J. Bevevino</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Director</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ Ronald C. Elkins, M.D.</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Ronald C. Elkins, M.D.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Director</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ Ronald D. McCall</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Ronald D. McCall</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Director</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ Harvey Morgan</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Harvey Morgan</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Director</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:186.10pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">/s/ Jon W. Salveson</font></p>
					<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Jon W. Salveson</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:206.85pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">Director</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:104.55pt;padding:0pt 6.9pt;">
					<p style="margin:6pt 0pt 0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">March 9</font><font style="display: inline;">, 2016</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">II-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">7</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;color:#000000;"></font>
		</p>
		<p style="margin:12pt 0pt 18pt;text-indent:0pt;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">EXHIBIT INDEX</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:50.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:288.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:52.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:52.55pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:52.55pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:157.50pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Incorporated by reference herein</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Exhibit Number</font></p>
				</td>
				<td colspan="2" valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Description</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Form</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Date</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Exhibit Number</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2.1*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Agreement and Plan of Merger, dated May 14, 2012, by and among CryoLife, Inc., CL Crown, Inc., Hemosphere, Inc. and a Stockholder Representative.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">10-Q</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">7/31/12</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2.1</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2.2*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Agreement and Plan of Merger, dated as of December 22, 2015, by and among CryoLife, Inc., On-X Life Technologies Holdings, Inc., Cast Acquisition Corporation, Fortis Advisors LLC and each of the security holders who becomes a party thereto.&nbsp;&nbsp;Certain schedules and exhibits referenced in the Agreement and Plan of Merger have been omitted in accordance with Item 601(b)(2) of Regulation&nbsp;S&#x2013;K. A copy of any omitted schedule or exhibit will be furnished supplementally to the Securities and Exchange Commission upon request.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">8-K</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">1/25/16</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2.1</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.1*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Form of Certificate for Common Stock of CryoLife, Inc.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">10-K</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">2/19/98</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.2</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.2*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Registration Rights Agreement, dated as of January 20, 2016, by and between CryoLife, Inc. and the investors parties thereto.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">8-K</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">1/25/16</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.1</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.3*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Form of Indenture for Senior Debt Securities</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">S-3</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">8/5/15</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.7</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.4*</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Form of Subordinated Indenture for Subordinated Debt Securities</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">S-3</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">8/5/15</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">4.9</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">5.1**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Opinion of Shutts and Bowen LLP</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">23.1**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Consent of Shutts and Bowen LLP (included in Exhibit&nbsp;5.1 to this Registration Statement)</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;height:11.70pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">23.2**</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.45pt;height:11.70pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="text-indent:0pt;margin-left:0pt; padding-right:182.95pt;"><font style="display: inline;font-size:9pt;">Consent of Ernst&nbsp;&amp; Young LLP </font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:right"><font style="display: inline;font-size:9pt;"></font></font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.70pt;height:11.70pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;height:11.70pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;height:11.70pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">23.3**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Consent of KPMG LLP</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">23.4**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Consent of Padgett Stratemann &amp; Co., LLP</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:50.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">24.1**</font></p>
				</td>
				<td colspan="2" valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:288.75pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Power of Attorney (contained in the signature page to this Registration Statement)</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:52.40pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:52.55pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-indent:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 2pt;line-height:65%;text-indent:0pt;text-decoration:underline;font-family:Times New Roman;font-size: 11pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:106pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;"></font></font>
		</p>
		<p style="margin:12pt 0pt 0pt 18pt;text-indent:-18pt;font-family:Times New Roman;font-size: 9pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:18pt;">
			<tr>
				<td valign="top" style="width:18.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:234.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:36pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:18.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">*</font></p>
				</td>
				<td valign="top" style="width:234.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Incorporated by reference herein.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:18.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">**</font></p>
				</td>
				<td valign="top" style="width:234.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:12pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Filed herewith.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;text-indent:0pt;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;">II-</font><font style="font-family:Times New Roman;font-size:11pt;display: inline;">8</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>c199-20160309ex51f92c8d9.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 5.17.1.24-->
<!--Created on: 3/9/2016 4:38:10 PM-->
<html>
	<head>
		<title>
			S-3 Registration Statement Exh 51  3-9-16
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Exhibit </font><font style="display: inline;">5</font><font style="display: inline;">.1</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Robert C. Brighton, Jr.</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">Partner</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">Shutts &amp; Bowen LLP</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">200</font><font style="display: inline;font-size:9pt;"> East Broward Blvd</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">Suite 2100</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">Fort Lauderdale, FL 33301</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">Direct (954) 847-3840</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">Fax (954) 527-7940</font>

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">Email&nbsp;&nbsp;rbrighton@shutts.com</font>

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<a name="_GoBack"></a><font style="display: inline;">March </font><font style="display: inline;">9</font><font style="display: inline;">, 2016</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">CryoLife, Inc.</font>
		</p>
		<p style="margin:0pt;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">1655 Roberts Boulevard, NW</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:0pt;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Kennesaw, Georgia 30144</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 5.75pt 0pt 72pt;text-indent:-36pt;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Re:</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">CryoLife, Inc.</font><br /><font style="display: inline;">Registration Statement on Form S-3</font><br /><font style="display: inline;">File No. 333-</font>
		</p>
		<p style="margin:12pt 0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Ladies and Gentlemen:</font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-bottom:1pt none #D9D9D9 ;text-indent:36pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">We have acted as special counsel to CryoLife, Inc., a Florida corporation (the &#x201C;</font><font style="display: inline;font-weight:bold;">Company</font><font style="display: inline;">&#x201D;), for Florida law issues in connection with the </font><font style="display: inline;">preparation and </font><font style="display: inline;">filing on </font><font style="display: inline;">March</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">9</font><font style="display: inline;">, 2016 with the Securities Exchange Commission (the &#x201C;</font><font style="display: inline;font-weight:bold;">Commission</font><font style="display: inline;">&#x201D;) of a registration statement on Form S-3 (the &#x201C;</font><font style="display: inline;font-weight:bold;">Registration Statement</font><font style="display: inline;">&#x201D;) under the Securities Act of 1933, as amended (the &#x201C;</font><font style="display: inline;font-weight:bold;">Act</font><font style="display: inline;">&#x201D;), pertaining to the registration of </font><font style="display: inline;">3,703,699 </font><font style="display: inline;">shares </font><font style="display: inline;">(the &#x201C;</font><font style="display: inline;font-weight:bold;">Offered Shares</font><font style="display: inline;">&#x201D;) </font><font style="display: inline;">of common stock (the &#x201C;</font><font style="display: inline;font-weight:bold;">Common Stock</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;">.&nbsp;&nbsp;The Registration Statement relates to the possible sale from time to time of the Offered Shares by the </font><font style="display: inline;">selling shareholders (&#x201C;</font><font style="display: inline;font-weight:bold;">Selling Shareholders</font><font style="display: inline;">&#x201D;) identified in the Registration Statement, any pre-effective amendment to the Registration Statement and any prospectus supplements to the final prospectus included as part of the Registration Statement (collectively, the &#x201C;</font><font style="display: inline;font-weight:bold;">Prospectus</font><font style="display: inline;">&#x201D;)</font><font style="display: inline;"> on a delayed or continuous basis</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">pursuant to Rule 415 of the General Rules and Regulations promulgated under the Act.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:36pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">You have provided use with a draft of the Registration Statement in the form in which it will be filed, which includes a form of Prospectus.&nbsp;&nbsp;The Prospectus provides that it will be supplemented in the future by one or more supplements to the prospectus in connection with each offering of the Offered Shares. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:36pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">This opinion letter is being delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining the contents of the Registration Statement or the Prospectus, other than as to the validity of Offered Shares as set forth below. </font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:36pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">As counsel to the Company, we have examined originals or copied, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary for the purposes of rendering this opinion letter and we are familiar with the proceedings taken and proposed to be taken by the Company in connection with the authorization, issuance and sale of the Offered Shares.&nbsp;&nbsp;In our </font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt 0pt 12pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;">examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity with the originals of all documents submitted to us as copies.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:36pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">We have further assumed that the Offered Shares will be sold in the manner stated in the Registration Statement and the Prospectus and in compliance with the applicable provisions of the Act and the rules and regulations of the Commission thereunder and the securities or blue sky laws of the applicable states.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:36pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Based upon, and subject to and limited by the</font><font style="display: inline;"> foregoing, we are of the opinion</font><font style="display: inline;"> that the Offered Shares have been validly issued, and are fully paid and nonasses</font><font style="display: inline;">s</font><font style="display: inline;">able.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-top:1pt none #D9D9D9 ;text-indent:36pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">We hereby consent to the filing of this opinion letter with the Commission as an Exhibit to the Registration Statement, and we consent to the reference to our name under the caption &#x201C;Legal Matters&#x201D; in the Prospectus.&nbsp;&nbsp;In giving such consent, we do not thereby admit that we are in the category of person whose consent is required under Section 7 of the Act.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 234pt;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Sincerely,</font>
		</p>
		<p style="margin:0pt 0pt 0pt 234pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 234pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">/s/ Shutts &amp; Bowen LLP</font>
		</p>
		<p style="margin:12pt 0pt 0pt 234pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;text-transform:uppercase;">Shutts &amp; Bowen LLP</font>
		</p>
		<p style="margin:0pt 0pt 0pt 234pt;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>c199-20160309ex2320b6a3e.htm
<DESCRIPTION>EX-23.2
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 5.17.1.24-->
<!--Created on: 3/9/2016 4:38:14 PM-->
<html>
	<head>
		<title>
			S-3 Registration Statement Exh 232  3-7-16
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Calibri;font-size: 11pt">

			<font style="display: inline;font-family:Times New Roman;">Exhibit 23.2</font>

		</p>

</div>
		<p style="margin:0pt;line-height:normal;text-align:right;font-family:Calibri;font-size: 11pt">
			<a name="_GoBack"></a><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Calibri;line-height:115%;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">Consent of Independent Registered Public Accounting Firm</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Calibri;line-height:115%;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">We consent to the reference to our firm under the caption "Experts" in th</font><font style="display: inline;font-family:Times New Roman;">is</font><font style="display: inline;font-family:Times New Roman;"> Registration Statemen</font><font style="display: inline;font-family:Times New Roman;">t &nbsp;</font><font style="display: inline;font-family:Times New Roman;">(</font><font style="display: inline;font-family:Times New Roman;">Form S-3</font><font style="display: inline;font-family:Times New Roman;">)</font><font style="display: inline;font-family:Times New Roman;"> and r</font><font style="display: inline;font-family:Times New Roman;">elated Prospectus of CryoLife, Inc.</font><font style="display: inline;font-family:Times New Roman;"> for the registration of </font><font style="display: inline;font-family:Times New Roman;">3,703,699 shares of </font><font style="display: inline;font-family:Times New Roman;">its </font><font style="display: inline;font-family:Times New Roman;">common stock</font><font style="display: inline;font-family:Times New Roman;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;">and to the incorporation </font><font style="display: inline;font-family:Times New Roman;">by reference therein of ou</font><font style="display: inline;font-family:Times New Roman;">r report</font><font style="display: inline;font-family:Times New Roman;">s</font><font style="display: inline;font-family:Times New Roman;"> dated </font><font style="display: inline;font-family:Times New Roman;">February 16, 2016</font><font style="display: inline;font-family:Times New Roman;">, with respect to the consolidated financial statements of </font><font style="display: inline;font-family:Times New Roman;">CryoLife, Inc. </font><font style="display: inline;font-family:Times New Roman;">and the effectiveness of internal control over financial reporting of </font><font style="display: inline;font-family:Times New Roman;">CryoLife, Inc.</font><font style="display: inline;font-family:Times New Roman;">,</font><font style="display: inline;font-family:Times New Roman;"> included in its Annual Report (Form 10-K) for </font><font style="display: inline;font-family:Times New Roman;">the year ended December 31, 2015</font><font style="display: inline;font-family:Times New Roman;">, filed with the Securities and Exchange Commission.</font>
		</p>
		<p style="margin:0pt 0pt 10pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">/s/ Ernst &amp; Young</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">Atlanta, Georgia</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">March 9</font><font style="display: inline;font-family:Times New Roman;">, 2016</font><font style="display: inline;font-family:Times New Roman;"></font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>4
<FILENAME>c199-20160309ex233688e12.htm
<DESCRIPTION>EX-23.3
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 5.17.1.24-->
<!--Created on: 3/9/2016 4:38:19 PM-->
<html>
	<head>
		<title>
			S-3 Registration Statement Exh 233  3-7-16
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Calibri;font-size: 11pt">

			<font style="display: inline;font-family:Times New Roman;">EXHIBIT 23.3</font>

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;background-color: #FFFFFF;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			<a name="_GoBack"></a><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;background-color: #FFFFFF;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;">Consent of Independent Auditors</font>
		</p>
		<p style="margin:12pt 0pt 0pt;background-color: #FFFFFF;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">We consent to the use of our report dated </font><font style="display: inline;font-family:Times New Roman;">April 29</font><font style="display: inline;font-family:Times New Roman;">, 20</font><font style="display: inline;font-family:Times New Roman;">15, with respect to the </font><font style="display: inline;font-family:Times New Roman;">consolidated balance sheet of </font><font style="display: inline;font-family:Times New Roman;color:#000000;">On-X Life Technologies Holdings, Inc. and subsidiaries</font><font style="display: inline;font-family:Times New Roman;"> as of December 31, 20</font><font style="display: inline;font-family:Times New Roman;">14, and the related consolidated</font><font style="display: inline;font-family:Times New Roman;"> statements of </font><font style="display: inline;font-family:Times New Roman;">income</font><font style="display: inline;font-family:Times New Roman;">, &nbsp;</font><font style="display: inline;font-family:Times New Roman;">shareholders&#x2019; deficit and</font><font style="display: inline;font-family:Times New Roman;"> cash flows for the year </font><font style="display: inline;font-family:Times New Roman;">then</font><font style="display: inline;font-family:Times New Roman;"> ended, incorporated herein by reference </font><font style="display: inline;font-family:Times New Roman;">to the Form 8-K</font><font style="display: inline;font-family:Times New Roman;">/A</font><font style="display: inline;font-family:Times New Roman;"> of CryoLife, Inc.</font><font style="display: inline;font-family:Times New Roman;"> dated </font><font style="display: inline;font-family:Times New Roman;">March </font><font style="display: inline;font-family:Times New Roman;">9</font><font style="display: inline;font-family:Times New Roman;">, 2016,</font><font style="display: inline;font-family:Times New Roman;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;">and to the reference to our firm under the heading "Experts" in the </font><font style="display: inline;font-family:Times New Roman;">registration statement</font><font style="display: inline;font-family:Times New Roman;">. &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">/s/ </font><font style="display: inline;font-family:Times New Roman;">KPMG LLP</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">Austin, Texas</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">March 8</font><font style="display: inline;font-family:Times New Roman;">, 2016</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>5
<FILENAME>c199-20160309ex234a5c024.htm
<DESCRIPTION>EX-23.4
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 5.17.1.24-->
<!--Created on: 3/9/2016 4:38:23 PM-->
<html>
	<head>
		<title>
			S-3 Registration Statement Exh 234  3-7-16
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Calibri;font-size: 11pt">

			<font style="display: inline;font-family:Times New Roman;">EXHIBIT 23.4</font>

		</p>

</div>
		<p style="margin:0pt;text-align:center;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Arial;font-size: 11pt">
			<a name="_GoBack"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:11pt;">Consent of Independent</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:11pt;"> Auditor</font><br /><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Arial;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">We consent to the use of our report dated April 7, 2014, with respect to the consolidated financial statements of </font><font style="display: inline;font-family:Times New Roman;color:#000000;">On-X Life Technologies Holdings, Inc. and subsidiaries</font><font style="display: inline;font-family:Times New Roman;"> as of December 31, 2013, incorporated herein by reference to the Form 8-K/A of CryoLife, Inc. dated March 9, 2016, and to the reference to our firm under the heading "Experts" in the registration statement. </font>
		</p>
		<p style="margin:5pt 0pt;text-align:justify;text-justify:inter-ideograph;line-height:115%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Arial;font-size: 11pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Arial;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-size:11pt;">/s/ Padgett, Stratemann &amp; Co., L.L.P.</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Arial;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-size:11pt;">Austin, Texas </font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Arial;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-size:11pt;">March 8, 2016</font>
		</p>
		<p style="margin:0pt;line-height:normal;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
